Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
16 "Triglyceride"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Association between the Triglyceride-Glucose Index and Cardiovascular Risk and Mortality across Different Diabetes Durations: A Nationwide Cohort Study
Jeongeun Kwak, Kyung-Do Han, Eun Young Lee, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Jeongmin Lee
Received October 15, 2024  Accepted January 3, 2025  Published online March 5, 2025  
DOI: https://doi.org/10.3803/EnM.2024.2205    [Epub ahead of print]
  • 486 View
  • 40 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We aimed to assess the association between triglyceride-glucose (TyG) index and cardiovascular disease (CVD) risk and mortality in a large cohort of diabetes patients.
Methods
A retrospective cohort study of 1,090,485 participants from the Korean National Health Insurance Service database was conducted. Participants were stratified into TyG quartiles.
Results
Higher TyG index quartiles were significantly associated with an increased CVD risk and mortality risk. In fully adjusted models, participants in the highest TyG quartile (Q4) had an 18% higher risk of CVD (hazard ratio [HR], 1.18; 95% confidence interval [CI], 1.13 to 1.23) and a 16% higher risk of mortality (HR, 1.16; 95% CI, 1.11 to 1.23) compared to those in the lowest quartile (Q1). The association was particularly pronounced in patients with fasting glucose ≥126 mg/dL (CVD [HR, 1.33; 95% CI, 1.29 to 1.37], mortality [HR, 1.23; 95% CI, 1.20 to 1.26]; P for interaction <0.001). Patients with a diabetes duration of ≥10 years showed the strongest association between the TyG index and CVD risk (HR, 1.44; 95% CI, 1.38 to 1.50), while the mortality risk was particularly elevated in those with a diabetes duration of less than 5 years (HR, 1.23; 95% CI, 1.18 to 1.30). Subgroup analyses revealed stronger associations between TyG index and CVD risk in younger participants, non-obese individuals, and non-smokers.
Conclusion
The TyG index is a significant predictor of CVD and mortality in diabetic patients, particularly in those with poor glycemic control or longer disease duration.
Close layer
Diabetes, obesity and metabolism
Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study
Joon Ho Moon, Yongkang Kim, Tae Jung Oh, Jae Hoon Moon, Soo Heon Kwak, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi, Nam H. Cho
Endocrinol Metab. 2023;38(4):406-417.   Published online August 3, 2023
DOI: https://doi.org/10.3803/EnM.2023.1703
  • 10,368 View
  • 293 Download
  • 17 Web of Science
  • 18 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
While the triglyceride-glucose (TyG) index is a measure of insulin resistance, its association with cardiovascular disease (CVD) has not been well elucidated. We evaluated the TyG index for prediction of CVDs in a prospective large communitybased cohort.
Methods
Individuals 40 to 70 years old were prospectively followed for a median 15.6 years. The TyG index was calculated as the Ln [fasting triglycerides (mg/dL)×fasting glucose (mg/dL)/2]. CVDs included any acute myocardial infarction, coronary artery disease or cerebrovascular disease. We used a Cox proportional hazards model to estimate CVD risks according to quartiles of the TyG index and plotted the receiver operating characteristics curve for the incident CVD.
Results
Among 8,511 subjects (age 51.9±8.8 years; 47.5% males), 931 (10.9%) had incident CVDs during the follow-up. After adjustment for age, sex, body mass index, diabetes mellitus, hypertension, total cholesterol, smoking, alcohol, exercise, and C-reactive protein, subjects in the highest TyG quartile had 36% increased risk of incident CVD compared with the lowest TyG quartile (hazard ratio, 1.36; 95% confidence interval, 1.10 to 1.68). Carotid plaque, assessed by ultrasonography was more frequent in subjects in the higher quartile of TyG index (P for trend=0.049 in men and P for trend <0.001 in women). The TyG index had a higher predictive power for CVDs than the homeostasis model assessment of insulin resistance (HOMA-IR) (area under the curve, 0.578 for TyG and 0.543 for HOMA-IR). Adding TyG index on diabetes or hypertension alone gave sounder predictability for CVDs.
Conclusion
The TyG index is independently associated with future CVDs in 16 years of follow-up in large, prospective Korean cohort.

Citations

Citations to this article as recorded by  
  • Elevated triglyceride-glucose index as a predictor of carotid plaque incidence: Insights from a comprehensive meta-analysis
    Arankesh Mahadevan, Bhavin A. Patel, Sashwath Srikanth, Raja Godasi, Rupak Desai
    The American Journal of the Medical Sciences.2025; 369(2): 197.     CrossRef
  • Analysis of the correlation between the serum triglyceride glucose index and the risk of death in patients on maintenance hemodialysis: a retrospective cohort study
    Xiaokeng Chi, Shuxin Chen, Zhe Huang, Rong Zhou, Zhicheng Su, Qiujun Mai, Yilin Xu, Jianxin Wan
    PeerJ.2025; 13: e18781.     CrossRef
  • Assessing the predictive value of elevated triglycerides, triglyceride-glucose index (TyG), and TG/HDL ratios for cardiovascular disease and mortality during 20 years of follow-up: Tehran lipid and glucose study
    Shayesteh Khalili, Atieh Amouzegar, Seyed Sattar Dorost, Fereidoun Azizi, Aryan Salahi-Niri
    Clinical Biochemistry.2025; 136: 110891.     CrossRef
  • Association between triglyceride-glucose index and carotid atherosclerosis in Chinese steelworkers: a cross-sectional study
    Haoyue Cao, Qinglin Li, Juxiang Yuan
    Scientific Reports.2025;[Epub]     CrossRef
  • Association between the triglyceride-glucose index and silent myocardial infarction in the general population
    Min Dai, Dongze Li, Jing Yu, Yi Liu, Qin Zhang, Wei Zhang, Yan Zhong, Zhi Wan, Menglin Tang, Yongli Gao, Li Rao
    Scientific Reports.2025;[Epub]     CrossRef
  • Integrative Multi‐Omics and Routine Blood Analysis Using Deep Learning: Cost‐Effective Early Prediction of Chronic Disease Risks
    Zhibin Dong, Pei Li, Yi Jiang, Zhihan Wang, Shihui Fu, Hebin Che, Meng Liu, Xiaojing Zhao, Chunlei Liu, Chenghui Zhao, Qin Zhong, Chongyou Rao, Siwei Wang, Suyuan Liu, Dayu Hu, Dongjin Wang, Juntao Gao, Kai Guo, Xinwang Liu, En Zhu, Kunlun He
    Advanced Science.2025;[Epub]     CrossRef
  • Impact of steatotic liver disease categories on atrial fibrillation in type 2 diabetes: a nationwide study
    So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus
    Kaisheng Yuan, Bing Wu, Ruiqi Zeng, Fuqing Zhou, Ruixiang Hu, Cunchuan Wang
    Diabetes, Obesity and Metabolism.2024; 26(1): 169.     CrossRef
  • Association between the triglyceride glucose index and chronic total coronary occlusion: A cross-sectional study from southwest China
    Kaiyong Xiao, Huili Cao, Bin Yang, Zhe Xv, Lian Xiao, Jianping Wang, Shuiqing Ni, Hui Feng, Zhongwei He, Lei Xv, Juan Li, Dongmei Xv
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(4): 850.     CrossRef
  • The association between TyG and all-cause/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999–2018
    Younan Yao, Bo Wang, Tian Geng, Jiyan Chen, Wan Chen, Liwen Li
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults
    Cancan Cui, Yitian Qi, Jiayin Song, Xinyun Shang, Tianjiao Han, Ning Han, Siqi Yue, Yining Zha, Zhonghang Xu, Jiannan Li, Lin Liu
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Triglyceride-glucose index predicts type 2 diabetes mellitus more effectively than oral glucose tolerance test-derived insulin sensitivity and secretion markers
    Min Jin Lee, Ji Hyun Bae, Ah Reum Khang, Dongwon Yi, Mi Sook Yun, Yang Ho Kang
    Diabetes Research and Clinical Practice.2024; 210: 111640.     CrossRef
  • Prognostic value of triglyceride-glucose index for left ventricular remodeling in nondiabetic ST-elevation myocardial infarction patients
    Tolga Han Efe, Engin Algül
    Biomarkers in Medicine.2024; 18(6): 243.     CrossRef
  • Triglyceride-Glucose Index as Predictor for Hypertension, CHD and STROKE Risk among Non-Diabetic Patients: A NHANES Cross-Sectional Study 2001–2020
    Bisher Sawaf, Sarya Swed, Hidar Alibrahim, Haidara Bohsas, Tirth Dave, Mohamad Nour Nasif, Wael Hafez, Fatema Ali Asgar Tashrifwala, Yazan Khair Eldien Jabban, Safwan Al-Rassas, Heba haj Saleh, Abdul Rehman Zia Zaidi, Baraa Alghalyini, Shaymaa Abdelmaboud
    Journal of Epidemiology and Global Health.2024; 14(3): 1152.     CrossRef
  • An Increasing Triglyceride–Glucose Index Is Associated with a Pro-Inflammatory and Pro-Oxidant Phenotype
    Beverley Adams-Huet, Ishwarlal Jialal
    Journal of Clinical Medicine.2024; 13(13): 3941.     CrossRef
  • Inflammatory and Metabolic Predictors of Mortality in Pulmonary Thromboembolism: A Focus on the Triglyceride–Glucose Index and Pan-Immune Inflammation Value
    Murat Bilgin, Emre Akkaya, Recep Dokuyucu
    Journal of Clinical Medicine.2024; 13(19): 6008.     CrossRef
  • The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes
    Verena Gounden, Sridevi Devaraj, Ishwarlal Jialal
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS)
    Alireza Jafari, Hamid Najafipour, Mitra Shadkam, Sina Aminizadeh
    Lipids in Health and Disease.2023;[Epub]     CrossRef
Close layer
Review Article
Diabetes, Obesity and Metabolism
Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
Joon Ho Moon, Kyuho Kim, Sung Hee Choi
Endocrinol Metab. 2022;37(4):575-586.   Published online August 29, 2022
DOI: https://doi.org/10.3803/EnM.2022.402
  • 36,943 View
  • 713 Download
  • 26 Web of Science
  • 28 Crossref
AbstractAbstract PDFPubReader   ePub   
High levels of triglycerides (TG) and triglyceride-rich lipoproteins (TGRLs) confer a residual risk of cardiovascular disease after optimal low-density lipoprotein cholesterol (LDL-C)–lowering therapy. Consensus has been made that LDL-C is a non-arguable primary target for lipid lowering treatment, but the optimization of TGRL for reducing the remnant risk of cardiovascular diseases is urged. Omega-3 fatty acids and fibrates are used to reduce TG levels, but many patients still have high TG and TGRL levels combined with low high-density lipoprotein concentration that need to be ideally treated. Lipoprotein lipase (LPL) is a key regulator for TGs that hydrolyzes TGs to glycerol and free fatty acids in lipoprotein particles for lipid storage and consumption in peripheral organs. A deeper understanding of human genetics has enabled the identification of proteins regulating the LPL activity, which include the apolipoproteins and angiopoietin-like families. Novel therapeutic approach such as antisense oligonucleotides and monoclonal antibodies that regulate TGs have been developed in recent decades. In this article, we focus on the biology of LPL and its modulators and review recent clinical application, including genetic studies and clinical trials of novel therapeutics. Optimization of LPL activity to lower TG levels could eventually reduce incident atherosclerotic cardiovascular disease in conjunction with successful LDL-C reduction.

Citations

Citations to this article as recorded by  
  • The Relationship Between Remnant Cholesterol and Visceral Adipose Tissue: A National Cross-Sectional Study
    Zhaoxiang Wang, Shao Zhong, Menghuan Wu, Xuejing Shao, Tian Gu, Mengjiao Xu, Qichao Yang
    Hormone and Metabolic Research.2025; 57(01): 47.     CrossRef
  • Current and Emerging Treatment Options for Hypertriglyceridemia: State-of-the-Art Review
    Jakub Michal Zimodro, Manfredi Rizzo, Ioanna Gouni-Berthold
    Pharmaceuticals.2025; 18(2): 147.     CrossRef
  • Insights into Causal Associations of Lipid Traits and Lipid-modifying Drug Targets with Uric Acid and Risk of Gout
    Chenfeng Zou, Bei Yang, Jiaying Zhang, Yuying Zhang, Dewei Ye, Hanyu Zhu, Tao Bai, Guozhi Jiang
    Phenomics.2025;[Epub]     CrossRef
  • Associations of intra‐pancreatic fat deposition with triglyceride‐rich lipoproteins and lipoprotein lipase
    Yutong Liu, Loren Skudder‐Hill, Wandia Kimita, Xiatiguli Shamaitijiang, Ivana R. Sequeira‐Bisson, Maxim S. Petrov
    Diabetes, Obesity and Metabolism.2025;[Epub]     CrossRef
  • Association between atherogenic index of plasma level and cardiovascular events in patients with obstructive sleep apnea: The sleep heart health study
    Lixia Wang, Xinjie Hui, Rong Huang, Yi Xiao
    Sleep Medicine.2025; 129: 375.     CrossRef
  • HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
    Sebastià Alcover, Lisaidy Ramos-Regalado, Gabriela Girón, Natàlia Muñoz-García, Gemma Vilahur
    Antioxidants.2025; 14(4): 434.     CrossRef
  • The chylomicron saga: time to focus on postprandial metabolism
    Alejandro Gugliucci
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Sanghuangporus vaninii extract ameliorates hyperlipidemia in rats by mechanisms identified with transcriptome analysis
    Ning Gao, Yuanzhen Liu, Guangjie Liu, Bo Liu, Yupeng Cheng
    Food Science & Nutrition.2024; 12(5): 3360.     CrossRef
  • Targeting host-specific metabolic pathways—opportunities and challenges for anti-infective therapy
    Monika I. Konaklieva, Balbina J. Plotkin
    Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
  • Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
    Harold Edward Bays, Carol Kirkpatrick, Kevin C. Maki, Peter P. Toth, Ryan T. Morgan, Justin Tondt, Sandra Michelle Christensen, Dave Dixon, Terry A. Jacobson
    Obesity Pillars.2024; 10: 100108.     CrossRef
  • Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
    Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
    Diabetes & Metabolism Journal.2024; 48(2): 184.     CrossRef
  • Xanthohumol, a prenylated chalcone, regulates lipid metabolism by modulating the LXRα/RXR-ANGPTL3-LPL axis in hepatic cell lines and high-fat diet-fed zebrafish models
    Wan-Yun Gao, Pei-Yi Chen, Hao-Jen Hsu, Je-Wen Liou, Chia-Ling Wu, Ming-Jiuan Wu, Jui-Hung Yen
    Biomedicine & Pharmacotherapy.2024; 174: 116598.     CrossRef
  • Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
    Harold Edward Bays, Carol F. Kirkpatrick, Kevin C. Maki, Peter P. Toth, Ryan T. Morgan, Justin Tondt, Sandra Michelle Christensen, Dave L. Dixon, Terry A. Jacobson
    Journal of Clinical Lipidology.2024; 18(3): e320.     CrossRef
  • Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3‐year prospective cohort study
    Ming‐Ling Chang, Jennifer Tai, Jur‐Shan Cheng, Wei‐Ting Chen, Sien‐Sing Yang, Cheng‐Hsun Chiu, Rong‐Nan Chien
    Diabetes, Obesity and Metabolism.2024; 26(7): 2969.     CrossRef
  • Efficacy and safety of omega‐3‐acid ethyl acetate 90 capsules in severe hypertriglyceridemia: A randomized, controlled, multicenter study
    Wang Zhao, Yangang Wang, Jin Li, Tao Chen, Delu Yin, Hailong Dai, Zhuhua Yao, Shuiping Zhao
    Lipids.2024; 59(5): 145.     CrossRef
  • Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease
    Rui Shang, Brian Rodrigues
    Journal of Pharmacy & Pharmaceutical Sciences.2024;[Epub]     CrossRef
  • Targeting Apolipoprotein C-III for the Management of Severe Hypertriglyceridemia: Current Research and Future Directions
    Mili Shah, Abisheikh Sharma, Mohammed Ayyad, Ethan Swartz, Danyaal Jafrani, Dhir Gala
    Cureus.2024;[Epub]     CrossRef
  • Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies
    Alejandro Gugliucci
    Journal of Clinical Medicine.2024; 13(17): 5229.     CrossRef
  • Proteo-genomic analyses in relatively lean Chinese adults identify proteins and pathways that affect general and central adiposity levels
    Andri Iona, Pang Yao, Alfred Pozarickij, Christiana Kartsonaki, Saredo Said, Neil Wright, Kuang Lin, Iona Millwood, Hannah Fry, Mohsen Mazidi, Baihan Wang, Yiping Chen, Huaidong Du, Ling Yang, Daniel Avery, Dan Schmidt, Dianjianyi Sun, Pei Pei, Jun Lv, Ca
    Communications Biology.2024;[Epub]     CrossRef
  • Molecular Pathways Linking High-Fat Diet and PM2.5 Exposure to Metabolically Abnormal Obesity: A Systematic Review and Meta-Analysis
    Sagrario Lobato, Víctor Manuel Salomón-Soto, Claudia Magaly Espinosa-Méndez, María Nancy Herrera-Moreno, Beatriz García-Solano, Ernestina Pérez-González, Facundo Comba-Marcó-del-Pont, Mireya Montesano-Villamil, Marco Antonio Mora-Ramírez, Claudia Mancilla
    Biomolecules.2024; 14(12): 1607.     CrossRef
  • High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis
    Franziska Schmalz, Janett Fischer, Hamish Innes, Stephan Buch, Christine Möller, Madlen Matz-Soja, Witigo von Schönfels, Benjamin Krämer, Bettina Langhans, Alexandra Klüners, Michael Soyka, Felix Stickel, Jacob Nattermann, Christian P. Strassburg, Thomas
    JHEP Reports.2023; 5(4): 100684.     CrossRef
  • Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations
    Dieter Lütjohann, Hans-Ulrich Klör, Frans Stellaard
    Nutrients.2023; 15(9): 2202.     CrossRef
  • Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and in vitro hepatic lipid homeostasis gene expression
    Tien-Yuan Wu, Ni Tien, Cheng-Li Lin, Yu-Cun Cheah, Chung Y. Hsu, Fuu-Jen Tsai, Yi-Jen Fang, Yun-Ping Lim
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
    Alejandro Gugliucci
    Journal of Clinical Medicine.2023; 12(13): 4399.     CrossRef
  • Sugar and Dyslipidemia: A Double-Hit, Perfect Storm
    Alejandro Gugliucci
    Journal of Clinical Medicine.2023; 12(17): 5660.     CrossRef
  • Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
    Sang Heon Suh, Soo Wan Kim
    Diabetes & Metabolism Journal.2023; 47(5): 612.     CrossRef
  • Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
    Elena Valeria Fuior, Evangelia Zvintzou, Theodosios Filippatos, Katerina Giannatou, Victoria Mparnia, Maya Simionescu, Anca Violeta Gafencu, Kyriakos E. Kypreos
    Biomedicines.2023; 11(10): 2696.     CrossRef
  • Developing a model to predict the early risk of hypertriglyceridemia based on inhibiting lipoprotein lipase (LPL): a translational study
    Julia Hernandez-Baixauli, Gertruda Chomiciute, Juan María Alcaide-Hidalgo, Anna Crescenti, Laura Baselga-Escudero, Hector Palacios-Jordan, Elisabet Foguet-Romero, Anna Pedret, Rosa M. Valls, Rosa Solà, Miquel Mulero, Josep M. Del Bas
    Scientific Reports.2023;[Epub]     CrossRef
Close layer
Original Articles
Clinical Study
Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults
Sang Bae Lee, Min Kyung Kim, Shinae Kang, Kahui Park, Jung Hye Kim, Su Jung Baik, Ji Sun Nam, Chul Woo Ahn, Jong Suk Park
Endocrinol Metab. 2019;34(2):179-186.   Published online May 20, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.2.179
  • 10,175 View
  • 195 Download
  • 105 Web of Science
  • 104 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Recently, the triglyceride glucose (TyG) index has been considered a surrogate marker of insulin resistance which is a well-known pathogenic factor in nonalcoholic fatty liver disease (NAFLD). However, few studies have investigated the relationship between the TyG index and NAFLD. Thus, we investigated the relationship between the TyG index and NAFLD and the effectiveness of the TyG index compared with the homeostasis model assessment of insulin resistance (HOMA-IR) in identifying NAFLD in Korean adults.

Methods

Participants of 4,986 who underwent ultrasonography in a health promotion center were enrolled. The TyG index was calculated as ln [fasting triglycerides (mg/dL)×fasting glucose (mg/dL)/2], and HOMA-IR was estimated. NAFLD was diagnosed by ultrasonography.

Results

Significant differences were observed in metabolic parameters among the quartiles of the TyG index. The prevalence of NAFLD significantly increased with increment in the TyG index. After adjusting for multiple risk factors, a logistic regression analysis was performed. When the highest and lowest quartiles of the TyG index and HOMA-IR were compared, the odds ratios for the prevalence of NAFLD were 2.94 and 1.93 (95% confidence interval, 2.32 to 3.72 and 1.43 to 2.61; both P for trend <0.01), respectively. According to the receiver operating characteristic analysis, the TyG index was superior to HOMA-IR in predicting NAFLD.

Conclusion

The TyG index and prevalence of NAFLD were significantly related and the TyG index was superior to HOMA-IR in predicting NAFLD in Korean adults.

Citations

Citations to this article as recorded by  
  • Triglyceride-glucose index as a marker for visceral obesity in patients with gastric cancer
    Junbo Zuo, Zhenhua Huang, Yan Ge, Xin Ding, Xiuhua Wang, Yan Huang
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • The Prognostic Value of the Triglyceride-Glucose and Fibrosis-4 Indices in Patients Undergoing Coronary Angiography: A Retrospective Cohort Analysis
    Amir Aker, Tom Tarchitzky, Yuval Avidan, Barak Zafrir
    CJC Open.2025; 7(4): 465.     CrossRef
  • Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus
    Mengmeng Hu, Jingyu Yang, Beibei Gao, Zhoulu Wu, Ying Wu, Dandan Hu, Qiong Shen, Lei Chen
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Predictive Value of the Triglyceride-Glucose Index for Metabolic-Associated Fatty Liver Disease in Individuals with Different Metabolic Obese Phenotypes
    Dan Lv, Zepu Wang, Huanxin Liu, Cuiqiao Meng
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 125.     CrossRef
  • Use of the FHTHWA Index as a Novel Approach for Predicting the Incidence of Diabetes in a Japanese Population Without Diabetes: Data Analysis Study
    Jiao Wang, Jianrong Chen, Ying Liu, Jixiong Xu
    JMIR Medical Informatics.2025; 13: e64992.     CrossRef
  • The predictive value of triglyceride-glucose-high density lipoprotein-body mass index (TGH-BMI) for different degrees of hepatic steatosis and liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
    Ying Li, Tianrong Pan, Yue Wang, Guojuan Wang, Fang Wang
    Clinical Nutrition ESPEN.2025; 66: 290.     CrossRef
  • Comparison of SPISE and METS-IR and Other Markers to Predict Insulin Resistance and Elevated Liver Transaminases in Children and Adolescents
    Kyungchul Song, Eunju Lee, Hye Sun Lee, Hana Lee, Ji-Won Lee, Hyun Wook Chae, Yu-Jin Kwon
    Diabetes & Metabolism Journal.2025; 49(2): 264.     CrossRef
  • The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD
    Haoxuan Zou, Jiejie Xie, Xiaopu Ma, Yan Xie, Xingshun Qi
    Canadian Journal of Gastroenterology and Hepatology.2025;[Epub]     CrossRef
  • Association of triglyceride-glucose index with bone mineral density and fracture: a systematic review
    Maryam Yousefiasl, Arezou Soltanattar, Ali Ezzatollahi Tanha, Pouria Azami, Maryam Alaei, Amir Ali Alamdari, Farhad Esmailsorkh, Amirhossein Habibzadeh, Shaghayegh Khanmohammadi
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • The triglyceride glucose-waist circumference is the best indicator for screening non-alcoholic fatty liver disease in middle-aged and elderly people
    Yin Yang, Yuan Luo, Jinchun Shi, Yunyu Yin, Xiangyu Du, Jia Guo, Hua Zhuang
    Nutrición Hospitalaria.2025;[Epub]     CrossRef
  • Triglyceride-glucose index is independently associated with fatty pancreas disease in Chinese elderly
    Weinuo Mi, Yuzhi Zhang, Qifeng Wang, Wenbo Ding, Xiaodong Mao, Yu Sun, Xingjia Li, Chao Liu, Shuhang Xu
    BMC Endocrine Disorders.2025;[Epub]     CrossRef
  • Comparison of triglyceride glucose index and other insulin resistance indexes in children with overweight and obesity
    Derya Kalyoncu, Melis Kavrak Kursun
    BMC Endocrine Disorders.2025;[Epub]     CrossRef
  • Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction
    Ming Liu, Jianyuan Pan, Ke Meng, Yuwei Wang, Xueqing Sun, Likun Ma, Xiaofan Yu
    Scientific Reports.2024;[Epub]     CrossRef
  • Triglyceride-glucose index is capable of identifying metabolically obese, normal-weight older individuals
    Bokun Kim, Keisuke Taniguchi, Tomonori Isobe, Sechang Oh
    Journal of Physiological Anthropology.2024;[Epub]     CrossRef
  • Comparison of triglyceride/glucose index and related parameters with Indian Diabetes Risk Score assessment in non-diabetic individuals visiting primary healthcare centre—A community-based cross-sectional study
    Sivapragasam Ramalingam, Amlan Kumar Kar, Rajini Senthil
    Journal of Family Medicine and Primary Care.2024; 13(1): 235.     CrossRef
  • Insulin resistance in NSCLC: unraveling the link between development, diagnosis, and treatment
    Shizhang Zhan, Liu Wang, Wenping Wang, Ruoran Li
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • The association between the triglyceride–glucose index and prognosis in postoperative renal cell carcinoma patients: a retrospective cohort study
    Guoliang Qin, Zhuang Sun, Yuxiang Jin, Xiangguo Ren, Zhaocun Zhang, Shuo Wang, Guanwen Zhou, Kun Huang, Haifeng Zhao, Xianzhou Jiang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Profiling triglyceride-glucose index in Filipinos with type 2 diabetes mellitus: a single-center study
    Chastene Christopher Flake, Madonna Morales-Valenzuela, Raphael Enrique Tiongco, Annalyn Navarro
    The Egyptian Journal of Internal Medicine.2024;[Epub]     CrossRef
  • Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction–Associated Fatty Liver Disease
    A. Lum Han, Hee Kyung Lee, Sae Ron Shin
    Metabolic Syndrome and Related Disorders.2024; 22(5): 402.     CrossRef
  • Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study
    Emanuel Fryk, Vagner Ramon Rodrigues Silva, Lena Strindberg, Robin Strand, Håkan Ahlström, Karl Michaëlsson, Joel Kullberg, Lars Lind, Per-Anders Jansson
    International Journal of Obesity.2024; 48(8): 1180.     CrossRef
  • A Study of the Relationship Between the Triglyceride-Glucose Index and Skeletal Muscle Mass in a General Chinese Population
    Yue Liu, Hongwei Chen, Ziyi Wei, Tingting Han, Ningxin Chen, Yurong Weng, Yaomin Hu
    Clinical Medicine Insights: Endocrinology and Diabetes.2024;[Epub]     CrossRef
  • Triglyceride–glucose–alanine aminotransferase index: A noninvasive serum predictor for identifying the severity of pediatric nonalcoholic fatty liver disease
    Eu-Seon Noh, Il Tae Hwang
    Medicine.2024; 103(26): e38241.     CrossRef
  • Association between the C-reactive protein-triglyceride glucose index and erectile dysfunction in US males: results from NHANES 2001–2004
    Yangyang Mei, Yangmeina Li, Bo Zhang, Renfang Xu, Xingliang Feng
    International Journal of Impotence Research.2024;[Epub]     CrossRef
  • Triglyceride glucose index as a predictor for non-alcoholic fatty liver disease: insights from a longitudinal analysis in non-obese individuals
    Qi Ning, Keyang Zheng, Jiafu Yan, Chao Zhu
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • The nutritional metabolic risk index as a predictor of all-cause and cardiovascular mortality: A national cohort study
    Chuanwei Zhao, Yane Yang, Conghao Duan, Chenxuan Gao, Yansi Wang, Huan Ni, Lanping Zhou, Yunfang Xiang, MeiJu Li, Zhao Xu
    Clinical Nutrition ESPEN.2024; 63: 391.     CrossRef
  • Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease
    Bitgyeol Kim, Hye Young Jin, Jong Seo Yoon, Eu Seon Noh, Il Tae Hwang
    Journal of Clinical Research in Pediatric Endocrinology.2024;[Epub]     CrossRef
  • Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients
    Yuqing Cai, Jia Chen, Xiaoyu Deng, Biying Wang, Jiefeng Huang, Ningfang Lian
    BMC Pulmonary Medicine.2024;[Epub]     CrossRef
  • Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis
    Sandeep Samethadka Nayak, Dona Kuriyakose, Lakshmi D. Polisetty, Anjali Avinash Patil, Daniyal Ameen, Rakshita Bonu, Samatha P. Shetty, Pubali Biswas, Micheal T. Ulrich, Negin Letafatkar, Arman Habibi, Mohammad-Hossein Keivanlou, Sara Nobakht, Abdulhadi A
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Relationship between triglyceride-glucose index and endometriosis: a cross-sectional analysis
    Yue Cao, Qian Yang, Qiqing Mai, Jianxiong Wuliu, Kaixian Deng
    BMC Women's Health.2024;[Epub]     CrossRef
  • Association Between Triglyceride-Glucose Index and Lung Function Parameters in the General Population Undergoing Health Examinations
    Yu Yang, Shuqi Wang, Boying Jia, Shuchun Chen
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 4031.     CrossRef
  • Association of HOMA-IR Versus TyG Index with Diabetes in Individuals Without Underweight or Obesity
    Bokun Kim, Gwon-Min Kim, Up Huh, Juhyun Lee, Eunji Kim
    Healthcare.2024; 12(23): 2458.     CrossRef
  • The Triglyceride-Glucose Index is Associated with Vitamin D Status in Metabolic-Associated Fatty Liver Disease
    Zhiping Liu, Wensha Zhang, Zhiwei Zhao, Wenhao Li, Jinhua Zhang
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2651.     CrossRef
  • The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis
    Qin Ling, Jiawei Chen, Xiao Liu, Yi Xu, Jianyong Ma, Peng Yu, Kai Zheng, Fuwei Liu, Jun Luo
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Triglyceride–Glucose Index as a Potential Indicator of Sarcopenic Obesity in Older People
    Bokun Kim, Gwonmin Kim, Yongkook Lee, Keisuke Taniguchi, Tomonori Isobe, Sechang Oh
    Nutrients.2023; 15(3): 555.     CrossRef
  • Association of insulin resistance with bone mineral density in a nationwide health check-up population in China
    Ming Zhuo, Ze Chen, Mao-Lin Zhong, Fang Lei, Juan-Juan Qin, Shuhua Liu, Ye-Mao Liu, Tao Sun, Xiao-Jing Zhang, Lihua Zhu, Jingjing Cai, Jun-Ming Ye, Erping Yang
    Bone.2023; 170: 116703.     CrossRef
  • Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
    Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
    Diabetes & Metabolism Journal.2023; 47(2): 220.     CrossRef
  • Comparison of the prognostic value of a comprehensive set of predictors in identifying risk of metabolic-associated fatty liver disease among employed adults
    Ze Yang, Bin Yu, Zihang Wang, Zhitao Li, Bo Yang, Honglian Zeng, Shujuan Yang
    BMC Public Health.2023;[Epub]     CrossRef
  • The triglyceride glucose index and CDKAL1 gene rs10946398 SNP are associated with NAFLD in Chinese adults
    Jun ZHU, Dujuan XU, Ruihua YANG, Min LIU, Ying LIU
    Minerva Endocrinology.2023;[Epub]     CrossRef
  • PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content
    Ákos Nádasdi, Viktor Gál, Tamás Masszi, Anikó Somogyi, Gábor Firneisz
    Cardiovascular Diabetology.2023;[Epub]     CrossRef
  • Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study
    Yaqin Wang, Jiangang Wang, Lei Liu, Pingting Yang, Shuwen Deng, Xuelian Liu, Linlin Zhao, Changfa Wang, Ying Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Assessing temporal differences in the predictive power of baseline TyG-related parameters for future diabetes: an analysis using time-dependent receiver operating characteristics
    Maobin Kuang, Ruijuan Yang, Xin Huang, Chao Wang, Guotai Sheng, Guobo Xie, Yang Zou
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Metabolic Score for Insulin Resistance (METS-IR) Predicts Adverse Cardiovascular Events in Patients with Type 2 Diabetes and Ischemic Cardiomyopathy
    Xuehe Zhang, Fen Liu, Wenling Li, Jixin Zhang, Tong Zhang, Xiaolin Yu, Junyi Luo, Qian Zhao, Jinyu Zhang, Binbin Fang, Yining Yang, Xiaomei Li
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1283.     CrossRef
  • Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital Staff
    Daya Zhang, Lijun Zhang, Shiju Chen, Runxiang Chen, Xiaodong Zhang, Feihu Bai
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1221.     CrossRef
  • The metabolic score of insulin resistance is positively correlated with bone mineral density in postmenopausal patients with type 2 diabetes mellitus
    Peng Gu, Bin Pu, Qiao Xin, Dan Yue, LieLiang Luo, JiaSheng Tao, HaiShan Li, Ming Chen, MingHua Hu, XiaoRong Hu, XiaoHui Zheng, ZhanPeng Zeng
    Scientific Reports.2023;[Epub]     CrossRef
  • Prevalence estimates of the insulin resistance and associated prevalence of heart failure among United Status adults
    Xiaozhong Li, Jihong Wang, Liyan Niu, Ziqi Tan, Jianyong Ma, Ling He, Peng Yu, Xiao Liu, Juxiang Li
    BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
  • From NAFLD to HCC: Advances in noninvasive diagnosis
    Qinchen Xu, Maoxiao Feng, Yidan Ren, Xiaoyan Liu, Huiru Gao, Zigan Li, Xin Su, Qin Wang, Yunshan Wang
    Biomedicine & Pharmacotherapy.2023; 165: 115028.     CrossRef
  • Usefulness of two-dimensional shear wave elastography in the assessment of non-alcoholic fatty liver disease in children and adolescents
    Jong Seo Yoon, Kyoung Ja Lim, Il Tae Hwang
    Scientific Reports.2023;[Epub]     CrossRef
  • A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis
    Xiaojie He, Xinyue Huang, Yafang Qian, Ting Sun
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease
    Da-Hye Son, Jee Hye Han, Jun-Hyuk Lee
    Journal of Obesity & Metabolic Syndrome.2023; 32(3): 214.     CrossRef
  • Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population
    Kengo Moriyama, Nagamu Inoue, Jin Imai, Yumi Masuda, Chizumi Yamada, Noriaki Kishimoto, Shinji Takashimizu, Akira Kubo, Yasuhiro Nishizaki
    Metabolic Syndrome and Related Disorders.2023; 21(9): 489.     CrossRef
  • Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease
    Mengyuan Wang, Mingxing Chang, Peipu Shen, Wei Wei, Huayao Li, Guifang Shen
    Lipids in Health and Disease.2023;[Epub]     CrossRef
  • Homeostatic Model Assessment of Insulin Resistance as a Potential Screening Test for Non-Alcoholic Fatty Liver Disease in Korean Adults without Diabetes
    Hyejung Lee, Jae-Ho Lee
    Korean Journal of Family Practice.2023; 13(4): 233.     CrossRef
  • Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths
    Kyungchul Song, Goeun Park, Hye Sun Lee, Myeongseob Lee, Hae In Lee, Han Saem Choi, Junghwan Suh, Ahreum Kwon, Ho-Seong Kim, Hyun Wook Chae
    The Journal of Pediatrics.2022; 242: 79.     CrossRef
  • The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults
    Ehsaneh Taheri, Mohammad Amin Pourhoseingholi, Alireza Moslem, Amir Hossein Hassani, Alireza Mousavi Jarrahi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Behzad Hatami
    Journal of Diabetes & Metabolic Disorders.2022; 21(1): 97.     CrossRef
  • Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome
    Da-Hye Son, Hye Sun Lee, Yong-Jae Lee, Jun-Hyuk Lee, Jee-Hye Han
    Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(3): 596.     CrossRef
  • Triglycerides/Glucose Index Is Associated with Sperm Parameters and Sperm DNA Fragmentation in Primary Infertile Men: A Cross-Sectional Study
    Federico Belladelli, Luca Boeri, Edoardo Pozzi, Giuseppe Fallara, Christian Corsini, Luigi Candela, Walter Cazzaniga, Daniele Cignoli, Luca Pagliardini, Alessia D’Arma, Paolo Capogrosso, Eugenio Ventimiglia, Francesco Montorsi, Andrea Salonia
    Metabolites.2022; 12(2): 143.     CrossRef
  • Association of triglyceride-glucose index and stroke recurrence among nondiabetic patients with acute ischemic stroke
    Xiaomeng Yang, Guangyao Wang, Jing Jing, Anxin Wang, Xiaoli Zhang, Qian Jia, Xia Meng, Xingquan Zhao, Liping Liu, Hao Li, Yongjun Wang, Yilong Wang
    BMC Neurology.2022;[Epub]     CrossRef
  • The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients
    Benjamin Rivière, Audrey Jaussent, Valérie Macioce, Stéphanie Faure, Nicolas Builles, Patrick Lefebvre, Philippe Géraud, Marie-Christine Picot, Sandra Rebuffat, Eric Renard, Valérie Paradis, Marie-Dominique Servais, Nathalie de Preville, David Nocca, Anne
    Diabetes & Metabolism.2022; 48(4): 101345.     CrossRef
  • Association of triglyceride-glucose with cardiac hemodynamics in type 2 diabetes
    Chenxi Wang, Zhicong Zhao, Xia Deng, Zhensheng Cai, Tian Gu, Lian Li, Chang Guo, Dong Wang, Ling Yang, Li Zhao, Guoyue Yuan
    Diabetes and Vascular Disease Research.2022;[Epub]     CrossRef
  • Comparison of the Modified TyG Indices and Other Parameters to Predict Non-Alcoholic Fatty Liver Disease in Youth
    Kyungchul Song, Hae Won Lee, Han Saem Choi, Goeun Park, Hye Sun Lee, Su Jin Kim, Myeongseob Lee, Junghwan Suh, Ahreum Kwon, Ho-Seong Kim, Hyun Wook Chae
    Biology.2022; 11(5): 685.     CrossRef
  • Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals
    Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, Waseem Wahood, Sami Ghazaleh, Ziad Abuhelwa, Wasef Sayeh, Nameer Aladamat, Rami Musallam, Reem Matar, Saif-Eddin Malhas, Ragheb Assaly
    Journal of Clinical Medicine.2022; 11(9): 2666.     CrossRef
  • Triglyceride and Glucose Index as a Screening Tool for Nonalcoholic Liver Disease in Patients with Metabolic Syndrome
    Anca Maria Amzolini, Mircea-Cătălin Forțofoiu, Anca Barău Alhija, Ionela Mihaela Vladu, Diana Clenciu, Adina Mitrea, Maria Forțofoiu, Daniela Matei, Magdalena Diaconu, Marinela Sinziana Tudor, Elena Simona Micu
    Journal of Clinical Medicine.2022; 11(11): 3043.     CrossRef
  • Triglyceride glucose index is superior biomarker for predicting type 2 diabetes mellitus in children and adolescents
    Jong Seo Yoon, Hye Jin Lee, Hwal Rim Jeong, Young Suk Shim, Min Jae Kang, Il Tae Hwang
    Endocrine Journal.2022; 69(5): 559.     CrossRef
  • Triglyceride and glucose index is a simple and easy‐to‐calculate marker associated with nonalcoholic fatty liver disease
    Kyung‐Soo Kim, Sangmo Hong, Hong‐Yup Ahn, Cheol‐Young Park
    Obesity.2022; 30(6): 1279.     CrossRef
  • Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality
    Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
    Journal of General Internal Medicine.2022; 37(16): 4153.     CrossRef
  • The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
    Rossella Palma, Annamaria Pronio, Mario Romeo, Flavia Scognamiglio, Lorenzo Ventriglia, Vittorio Maria Ormando, Antonietta Lamazza, Stefano Pontone, Alessandro Federico, Marcello Dallio
    Journal of Clinical Medicine.2022; 11(13): 3649.     CrossRef
  • Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study
    Zhi Liu, He He, Yuzhao Dai, Lidan Yang, Shenling Liao, Zhenmei An, Shuangqing Li
    Lipids in Health and Disease.2022;[Epub]     CrossRef
  • Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population
    Maritza Pérez-Mayorga, Jose P. Lopez-Lopez, Maria A. Chacon-Manosalva, Maria G Castillo, Johanna Otero, Daniel Martinez-Bello, Diego Gomez-Arbelaez, Daniel D. Cohen, Patricio Lopez-Jaramillo, Federico Ravaioli
    Canadian Journal of Gastroenterology and Hepatology.2022; 2022: 1.     CrossRef
  • Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China
    Danting Li, Meiyu Zhang, Shengli Wu, Huiwen Tan, Nong Li
    Scientific Reports.2022;[Epub]     CrossRef
  • The triglyceride glucose index is associated with the cerebral small vessel disease in a memory clinic population
    Jiayu Zhang, Ming Hu, Yanqiu Jia, Shicong Zhao, Peiyuan Lv, Mingyue Fan, Yuanyuan Shi, Wei Jin
    Journal of Clinical Neuroscience.2022; 104: 126.     CrossRef
  • Integrating experimental model, LC-MS/MS chemical analysis, and systems biology approach to investigate the possible antidiabetic effect and mechanisms of Matricaria aurea (Golden Chamomile) in type 2 diabetes mellitus
    Yassin Ismail, Dina M. Fahmy, Maivel H. Ghattas, Mai M. Ahmed, Walaa Zehry, Samy M. Saleh, Dina M. Abo-elmatty
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Laboratory data clustering in defining population cohorts: Case study on metabolic indicators
    Ivan Pavicevic, Goran Miljus, Olgica Nedic
    Journal of the Serbian Chemical Society.2022; 87(9): 1025.     CrossRef
  • Association of triglyceride glucose-body mass index with non-small cell lung cancer risk: A case-control study on Chinese adults
    Feifei Wang, Ting He, Guoliang Wang, Tuo Han, Zhongqiang Yao
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study
    Ru Zhang, Qing Guan, Mengting Zhang, Yajie Ding, Zongzhe Tang, Hongliang Wang, Wei Zhang, Yue Chen, Rong Jiang, Yan Cui, Jie Wang
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 3167.     CrossRef
  • Association between the triglyceride-glucose (TyG) index and increased blood pressure in normotensive subjects: a population-based study
    Dong-Hwa Lee, Jong Eun Park, So Young Kim, Hyun Jeong Jeon, Jong-Hyock Park
    Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
  • Fructose consumption correlates with triglyceride-glucose index and glycemic status in healthy adults
    Eda Keskin, Havvanur Yoldas Ilktac
    Clinical Nutrition ESPEN.2022; 52: 184.     CrossRef
  • Associations Between Type 2 Diabetes Subtypes and Complications: Analysis of the Malaysia National Diabetes Registry
    Rasa Kazlauskaite, Nathan Ellermeier, Carrie Ngongo, Arunah Chandran, Pankaja Desai, Ethan Ritz, Rachel Nugent, Feisul Idzwan Mustapha
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Independent and combined effects of triglyceride-glucose index on prehypertension risk: a cross-sectional survey in China
    Hong Xie, Jian Song, Liangliang Sun, Xinxin Xie, Yehuan Sun
    Journal of Human Hypertension.2021; 35(3): 207.     CrossRef
  • Association of Triglyceride-Glucose Index with Bone Mineral Density in Non-diabetic Koreans: KNHANES 2008–2011
    Jee Hee Yoon, A Ram Hong, Wonsuk Choi, Ji Yong Park, Hee Kyung Kim, Ho-Cheol Kang
    Calcified Tissue International.2021; 108(2): 176.     CrossRef
  • Triglyceride‐Glucose Index (TyG) is associated with erectile dysfunction: A cross‐sectional study
    Mehmet Yilmaz, Mustafa Karaaslan, Senol Tonyali, Mecit Celik, Tuncay Toprak, Oner Odabas
    Andrology.2021; 9(1): 238.     CrossRef
  • Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity
    Mohammad E. Khamseh, Mojtaba Malek, Rowshanak Abbasi, Hoda Taheri, Maryam Lahouti, Fariba Alaei-Shahmiri
    Metabolic Syndrome and Related Disorders.2021; 19(3): 167.     CrossRef
  • Triglyceride and glucose index and the risk of gestational diabetes mellitus: A nationwide population-based cohort study
    Jung A Kim, Jinsil Kim, Eun Roh, So-hyeon Hong, You-Bin Lee, Sei Hyun Baik, Kyung Mook Choi, Eunjin Noh, Soon Young Hwang, Geum Joon Cho, Hye Jin Yoo
    Diabetes Research and Clinical Practice.2021; 171: 108533.     CrossRef
  • Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008–2011
    Jung A. Kim, Soon Young Hwang, Ji Hee Yu, Eun Roh, So-hyeon Hong, You-Bin Lee, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Nan Hee Kim, Sin Gon Kim, Sei Hyun Baik, Kyung Mook Choi
    Scientific Reports.2021;[Epub]     CrossRef
  • The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity
    Luis E. Simental-Mendía, César Javier Ortega-Pacheco, Elvira García-Guerrero, María Alejandra Sicsik-Aragón, Fernando Guerrero-Romero, Gerardo Martínez-Aguilar
    European Journal of Pediatrics.2021; 180(6): 1755.     CrossRef
  • Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up
    Anxin Wang, Guangyao Wang, Qian Liu, Yingting Zuo, Shuohua Chen, Boni Tao, Xue Tian, Penglian Wang, Xia Meng, Shouling Wu, Yongjun Wang, Yilong Wang
    Cardiovascular Diabetology.2021;[Epub]     CrossRef
  • Association Between Triglyceride Glucose Index and Non-Small Cell Lung Cancer Risk in Chinese Population
    Xin Yan, Yujuan Gao, Jingzhi Tong, Mi Tian, Jinghong Dai, Yi Zhuang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Triglyceride Glucose Index Is Associated With Arterial Stiffness and 10-Year Cardiovascular Disease Risk in a Chinese Population
    Wen Guo, Wenfang Zhu, Juan Wu, Xiaona Li, Jing Lu, Pei Qin, Cheng Zhu, Nianzhen Xu, Qun Zhang
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • An Analysis of the Potential Relationship of Triglyceride Glucose and Body Mass Index With Stroke Prognosis
    Zongyi Hou, Yuesong Pan, Yindong Yang, Xiaofan Yang, Xianglong Xiang, Yilong Wang, Zixiao Li, Xingquan Zhao, Hao Li, Xia Meng, Yongjun Wang
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
    Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez
    International Journal of Molecular Sciences.2021; 22(9): 4807.     CrossRef
  • Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study
    Helda Tutunchi, Fatemeh Naeini, Majid Mobasseri, Alireza Ostadrahimi
    Clinical Nutrition ESPEN.2021; 44: 483.     CrossRef
  • Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome
    M. Mirr, D. Skrypnik, P. Bogdański, M. Owecki
    Journal of Endocrinological Investigation.2021; 44(12): 2831.     CrossRef
  • Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
    Jing Liu, Liying Guan, Meng Zhao, Qihang Li, An Song, Ling Gao, Haiyan Lin, Jiajun Zhao
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2829.     CrossRef
  • Association between triglyceride-glucose index and thyroid function in euthyroid adults: The Korea National Health and Nutritional Examination Survey 2015
    Wonsuk Choi, Ji Yong Park, A. Ram Hong, Jee Hee Yoon, Hee Kyung Kim, Ho-Cheol Kang, Sun Young Lee
    PLOS ONE.2021; 16(7): e0254630.     CrossRef
  • Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus
    Mojtaba Malek, Mohammad E. Khamseh, Haleh Chehrehgosha, Sohrab Nobarani, Fariba Alaei-Shahmiri
    Endocrine.2021; 74(3): 538.     CrossRef
  • The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: A retrospective study based on the NHIS-HEALS cohort
    Joungyoun Kim, Sang-Jun Shin, Hee-Taik Kang, Claudio Passino
    PLOS ONE.2021; 16(11): e0259212.     CrossRef
  • A population-based study of TyG index distribution and its relationship to cardiometabolic risk factors in children and adolescents
    Jong Seo Yoon, Young Suk Shim, Hae Sang Lee, Il Tae Hwang, Jin Soon Hwang
    Scientific Reports.2021;[Epub]     CrossRef
  • Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China
    Jingrui Wang, Zhenzhen Su, Yijin Feng, Ruihan Xi, Jiamin Liu, Peixi Wang
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • The value of the triglyceride-glucose index in the diagnosis of insulin resistance in early forms of non-alcoholic fatty liver disease
    A. A. Shipovskaya, N. A. Larina, I. V. Kurbatova, O. P. Dudanova
    Experimental and Clinical Gastroenterology.2021; (10): 43.     CrossRef
  • Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects
    Hwi Seung Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Chang Hee Jung, Joong-Yeol Park, Hong-Kyu Kim, Woo Je Lee
    Journal of Clinical Medicine.2021; 11(1): 41.     CrossRef
  • Homeostasis model assessment of insulin resistance and lobular inflammation in nondiabetic patients with nonalcoholic fatty liver disease: methodological considerations
    Denis Monneret, Dominique Bonnefont-Rousselot
    European Journal of Gastroenterology & Hepatology.2020; 32(4): 542.     CrossRef
  • Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome
    Chen Chen, Caiyun Zhang, Xuelin Wang, Feijuan Zhang, Ze Zhang, Pengchai Ma, Shuzhi Feng
    European Journal of Gastroenterology & Hepatology.2020; 32(7): 857.     CrossRef
  • Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
    Kyung-Soo Kim, Byung-Wan Lee
    Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef
  • The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults
    Wen Guo, Jing Lu, Pei Qin, Xiaona Li, Wenfang Zhu, Juan Wu, Nianzhen Xu, Qun Zhang
    Lipids in Health and Disease.2020;[Epub]     CrossRef
  • Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study
    Yaling Li, Rui Zheng, Jie Li, Shuyi Feng, Li Wang, Zhiming Huang
    Lipids in Health and Disease.2020;[Epub]     CrossRef
Close layer
Diabetes
The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study
Yu Hyun Kwon, Seul-Ki Kim, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinol Metab. 2018;33(1):55-61.   Published online January 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.55
  • 5,574 View
  • 65 Download
  • 14 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Hypertriglyceridemia is known to have an association with increased risks of insulin resistance and diabetes. The aim of this study was to investigate the risk of diabetes mellitus, according to changes in the concentrations of triglycerides, over time.

Methods

A total of 15,932 non-diabetic participants (mean age 43.2 years, 68% men) who attended five consecutive annual health check-ups at Kangbuk Samsung Hospital, between January 2010 and December 2014, were recruited. Participants were classified according to their triglyceride concentrations; normal (<150 mg/dL) and abnormal (≥150 mg/dL). According to the triglyceride levels in 2010 and 2012, subjects were divided into four groups: normal-normal, normal-abnormal, abnormal-normal, and abnormal-abnormal. The risk for incident diabetes was assessed in 2014.

Results

Among the total subjects, 67.5% belonged to the normal-normal group, 8.6% to the normal-abnormal group, 9.4% to the abnormal-normal group, and 14.5% to the abnormal-abnormal group. A total of 234 subjects (1.5%) were newly diagnosed with diabetes, between 2010 and 2014. Over 4 years, 1%, 1.5%, 2.1%, and 3.0% of the subjects developed diabetes in the normal-normal, normal-abnormal, abnormal-normal, and abnormal-abnormal groups, respectively. When the risk for incident diabetes was analyzed in the groups, after adjusting the confounding variables, a 1.58-fold increase in the risk of diabetes (95% confidence interval [CI], 1.10 to 2.26) was observed in the participants with persistent hypertriglyceridemia (abnormal-abnormal group). This was attenuated by further adjustments for body mass index (BMI) (hazard ratio, 1.25; 95% CI, 0.86 to 1.80).

Conclusion

In this large study population, persistent hypertriglyceridemia, over a period of 2 years, was significantly associated with the risk of incident diabetes, which was attenuated after adjustment for BMI.

Citations

Citations to this article as recorded by  
  • Cumulative exposure to hypertriglyceridemia and risk of type 2 diabetes in young adults
    Min-Kyung Lee, Kyungdo Han, Bongsung Kim, Jong-Dai Kim, Moon Jung Kim, Byungpyo Kim, Jung Heo, Jiyeon Ahn, Seo-Young Sohn, Jae-Hyuk Lee
    Diabetes Research and Clinical Practice.2024; 208: 111109.     CrossRef
  • Usefulness of SPISE Index for Screening and Detection of Early Stages of Insulin Resistance among Chilean Young Adults
    Isabel Pereyra González, Sandra Lopez-Arana
    Annals of Nutrition and Metabolism.2023; 79(4): 372.     CrossRef
  • Lipid variability in patients with diabetes mellitus
    Jeongmin Lee, Seung-Hwan Lee
    Cardiovascular Prevention and Pharmacotherapy.2023; 5(4): 126.     CrossRef
  • Sesamin: A Promising Therapeutic Agent for Ameliorating Symptoms of Diabetes
    Shu-Ming Huang, Cheng-Hung Chuang, Christine Joyce F. Rejano, Lemmuel L. Tayo, Cheng-Yang Hsieh, Steven Kuan-Hua Huang, Po-Wei Tsai
    Molecules.2023; 28(21): 7255.     CrossRef
  • Variability, Mean, and Baseline Values of Metabolic Parameters in Predicting Risk of Type 2 Diabetes
    Duong Duc Pham, Jaekyung Song, Yunwan Jeon, Ibrahimi Hajar, Chae Hun Leem
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): 1270.     CrossRef
  • Lipid Variability and Diabetes Mellitus
    Jeongmin Lee, Seung-Hwan Lee
    The Journal of Korean Diabetes.2022; 23(1): 28.     CrossRef
  • The Risk of Type 2 Diabetes Mellitus in a Russian Population Cohort According to Data from the HAPIEE Project
    Svetlana V. Mustafina, Oksana D. Rymar, Liliya V. Shcherbakova, Evgeniy G. Verevkin, Hynek Pikhart, Olga V. Sazonova, Yuliya I. Ragino, Galina I. Simonova, Martin Bobak, Sofia K. Malyutina, Mikhail I. Voevoda
    Journal of Personalized Medicine.2021; 11(2): 119.     CrossRef
  • The influence of VDR polymorphisms on the type 2 diabetes susceptibility in Chinese: an interaction with hypertriglyceridemia
    Dongdong Zhang, Cheng Cheng, Yan Wang, Yuan Xue, Yaping Liu, Yiming Liu, Mingming Feng, Ze Xu, Wenjie Li, Xing Li
    Molecular Genetics and Genomics.2021; 296(4): 837.     CrossRef
  • Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study
    Shinje Moon, Ji-Yong Jang, Yumin Kim, Chang-Myung Oh
    Scientific Reports.2021;[Epub]     CrossRef
  • Hypertriglyceridemia as an Independent Predictor for Ten-Year Incidence of Diabetes in Thais
    Suranut Charoensri, Supatida Turnsaket, Chatlert Pongchaiyakul
    Vascular Health and Risk Management.2021; Volume 17: 519.     CrossRef
  • Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
    Eun-Jung Rhee
    Endocrinology and Metabolism.2020; 35(1): 85.     CrossRef
  • HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
    Seung-Hwan Lee, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Kyungdo Han, Mee Kyoung Kim
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5633.     CrossRef
  • Response: The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
    Eun-Jung Rhee, Yu Hyun Kwon
    Endocrinology and Metabolism.2018; 33(3): 425.     CrossRef
  • The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
    Mi Hae Seo
    Endocrinology and Metabolism.2018; 33(2): 305.     CrossRef
Close layer
Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension
Mohsen Janghorbani, Mohammad Reza Salamat, Ashraf Aminorroaya, Masoud Amini
Endocrinol Metab. 2017;32(2):221-229.   Published online May 19, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.221
  • 6,145 View
  • 55 Download
  • 25 Web of Science
  • 26 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of this study was to assess the utility of the visceral adiposity index (VAI) and the hypertriglyceridemic waist (HTGW) phenotype as possible hypertension (HTN) predictors in a high-risk population without diabetes and HTN.

Methods

Incident HTN over a 7-year follow-up was assessed among 1,375 first-degree non-diabetic and non-hypertensive relatives of consecutive patients with type 2 diabetes who were 30 to 70 years of age. HTN was defined as a blood pressure reading ≥140/90 mm Hg or the use of antihypertensive medications. We examined the incidence of HTN across VAI quintiles and four groups defined according to baseline fasting serum triglyceride (TG) levels and waist circumference (WC).

Results

The VAI and the HTGW phenotype at baseline were related to an increased risk for HTN. In comparison with the lowest VAI quintile, the highest VAI quintile showed a significant associated with HTN in an age- and gender-adjusted model (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.07 to 2.55). Those with HTGW were 2.3 times (OR, 2.27; 95% CI, 1.54 to 3.35) more likely to develop HTN than those with a normal WC and normal TG levels.

Conclusion

Greater VAI values weakly predicted HTN, whereas the HTGW phenotype was a stronger predictor of incident HTN in an Iranian high-risk population.

Citations

Citations to this article as recorded by  
  • Predictive ability of the Chinese visceral adiposity index for incident hypertension in working-aged Koreans
    Ju Young Jung, Chang-Mo Oh, Hyun chul Jo, Sung Keun Park
    Epidemiology and Health.2024; 46: e2024034.     CrossRef
  • Association of the visceral adiposity index with arterial stiffness in elderly Chinese population
    Yifan Fan, Zhe Wang, Xiaotao Zhao, Shouling Wu, Hongjie Chi
    The American Journal of the Medical Sciences.2023; 365(3): 279.     CrossRef
  • Visceral and subcutaneous fat, muscle mass, and liver volume as noninvasive predictors of the progress of non-alcoholic fatty liver disease
    Omar M. Mahmoud, Gehad Abd Elaziz Mahmoud, Haisam Atta, Wael A. Abbas, Hanan M. Ahmed, Mohamed A. A. Abozaid
    Egyptian Journal of Radiology and Nuclear Medicine.2023;[Epub]     CrossRef
  • Association between Hypertriglyceridemic-Waist Phenotype and Metabolic Abnormalities in Hypertensive Adults
    Kyung-A SHIN, Myung Shin KANG
    Korean Journal of Clinical Laboratory Science.2023; 55(2): 113.     CrossRef
  • Association of Hyper-Triglyceridemic Waist Phenotype and Diabetic Vascular Complication in the Chinese Population
    Kun Li, Bin Cao, Jing Ke, Longyan Yang, Dong Zhao
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2233.     CrossRef
  • The relationship between hypertriglyceridemic wait-to-height ratio and hypertension–diabetes comorbidity among older adult
    Ping Zhang, Yangyang Xiong, Menghan Chen, Huaide Zhang, Nan Sun, Fan Wu, Jiayu Yang, Yongcheng Ren
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population
    Yan Xuan, Ping Gao, Ying Shen, Sujie Wang, Xi Gu, Dou Tang, Xun Wang, FanFan Zhu, Leiqun Lu, Ling Chen
    Hormones.2022; 21(3): 437.     CrossRef
  • The Association Between Hypertriglyceridemic-Waist Phenotype and Chronic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional METAL Study
    Yan Xuan, Wen Zhang, Yuying Wang, Bin Wang, Yi Chen, Fangzhen Xia, Kun Zhang, Qing Li, Ningjian Wang, Yingli Lu
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1885.     CrossRef
  • Chinese Visceral Adiposity Index Is More Closely Associated With Hypertension and Prehypertension Than Traditional Adiposity Indices in Chinese Population: Results From the REACTION Study
    Binqi Li, Jie Wang, Xin Zhou, Yang Liu, Weiqing Wang, Zhengnan Gao, Xulei Tang, Li Yan, Qin Wan, Zuojie Luo, Guijun Qin, Lulu Chen, Guang Ning, Yiming Mu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Association between hypertriglyceridemic-waist phenotype and cardiovascular disease: A cohort study and meta-analysis
    Xiaowei Zheng, Xiao Ren, Minglan Jiang, Longyang Han
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • The association between visceral adiposity index and leukocyte telomere length in adults: results from National Health and Nutrition Examination Survey
    Yifan Fan, Yulin Guo, Jiuchang Zhong, Hongjie Chi, Xiaotao Zhao, Pixiong Su, Jie Gao, Mulei Chen
    Aging Clinical and Experimental Research.2022; 34(9): 2177.     CrossRef
  • Hypertriglyceridemic-waist phenotype is strongly associated with cardiovascular risk factor clustering in Chinese adolescents
    Rongrong Cai, Jinyu Zhou, Ling Bai, Yangyang Dong, Wenqing Ding
    Scientific Reports.2022;[Epub]     CrossRef
  • Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran
    Behrooz Hamzeh, Yahya Pasdar, Narmin Mirzaei, Roya Safari Faramani, Farid Najafi, Ebrahim Shakiba, Mitra Darbandi
    Lipids in Health and Disease.2021;[Epub]     CrossRef
  • Visceral adiposity index is positively associated with blood pressure: A systematic review
    Nathália Nogueira Leite, Bruna Clemente Cota, Ana Raquel Ernesto Manuel Gotine, Daniela Mayumi Usuda Prado Rocha, Patrícia Feliciano Pereira, Helen Hermana Miranda Hermsdorff
    Obesity Research & Clinical Practice.2021; 15(6): 546.     CrossRef
  • The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits
    Begoña de Cuevillas, Ismael Alvarez-Alvarez, Jose I. Riezu-Boj, Santiago Navas-Carretero, J. Alfredo Martinez
    Scientific Reports.2021;[Epub]     CrossRef
  • Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study
    Meizhen Gu, Weijun Huang, Xinyi Li, Yupu Liu, Fan Wang, Chao Fang, Ting Chen
    Nature and Science of Sleep.2021; Volume 13: 2165.     CrossRef
  • The Visceral Adipose Index in Relation to Incidence of Hypertension in Chinese Adults: China Health and Nutrition Survey (CHNS)
    Yong Xue, Qun Shen, Chang Li, Zijian Dai, Tingchao He
    Nutrients.2020; 12(3): 805.     CrossRef
  • Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
    Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
  • Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study
    Rokhsareh Meamar, Masoud Amini, Ashraf Aminorroaya, Maryam Nasri, Majid Abyar, Awat Feizi
    World Journal of Diabetes.2020; 11(5): 202.     CrossRef
  • Association between Visceral Adiposity Index and hypertension among Chinese Adults: a nationwide cross-sectional study in the China Health and Nutrition Survey
    Jing Yang, Hongxia Li, Lianhua Han, Lei Zhang, Yafeng Zhou
    Blood Pressure Monitoring.2020; 25(5): 271.     CrossRef
  • Hypertriglyceridemic Waist Phenotype and Lipid Accumulation Product: Two Comprehensive Obese Indicators of Waist Circumference and Triglyceride to Predict Type 2 Diabetes Mellitus in Chinese Population
    Minrui Xu, Mingtao Huang, Deren Qiang, Jianxin Gu, Yong Li, Yingzi Pan, Xingjuan Yao, Wenchao Xu, Yuan Tao, Yihong Zhou, Hongxia Ma, Ulrike Rothe
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis
    Yanbing Ding, Min Zhang, Lisheng Wang, Tao Yin, Ningzhi Wang, Jian Wu, Jiehua Zhi, Weiwei Chen, Keyan Wu, Weijuan Gong, Weiming Xiao, Zhenglei Xu, Guotao Lu
    Lipids in Health and Disease.2019;[Epub]     CrossRef
  • Association between the Hypertriglyceridemic Waist Phenotype and Prediabetes in Chinese Adults Aged 40 Years and Older
    Kun Zhao, Shan-Shan Yang, Hai-Bin Wang, Kang Chen, Zhao-Hui Lu, Yi-Ming Mu
    Journal of Diabetes Research.2018; 2018: 1.     CrossRef
  • Sex-specific relationship between visceral fat index and dyslipidemia in Chinese rural adults: The Henan Rural Cohort Study
    Zhongyan Tian, Yuqian Li, Zhenxing Mao, Songcheng Yu, Yanhua Wang, Xiaotian Liu, Runqi Tu, Haiqing Zhang, Xinling Qian, Xia Zhang, Lulu Zhang, Jingzhi Zhao, Lei Yin, Chongjian Wang
    Preventive Medicine.2018; 116: 104.     CrossRef
  • Response: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
    Mohsen Janghorbani
    Endocrinology and Metabolism.2017; 32(4): 485.     CrossRef
  • Letter: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
    Eun-Jung Rhee
    Endocrinology and Metabolism.2017; 32(3): 396.     CrossRef
Close layer
Review Articles
Prevalence and Clinical Characteristics of Dyslipidemia in Koreans
Jee-Sun Jeong, Hyuk-Sang Kwon
Endocrinol Metab. 2017;32(1):30-35.   Published online March 20, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.30
  • 6,678 View
  • 50 Download
  • 23 Web of Science
  • 26 Crossref
AbstractAbstract PDFPubReader   

The prevalence of hypercholesterolemia in Koreans 30 years old and over was 19.5% in 2015 according to the Korean Nutrition and Health Examination Survey, which means that one-fifth of adults had hypercholesterolemia. The prevalence of hypertriglyceridemia in adults 30 years of age and older was 16.8% in 2015, and men had a 2-fold higher prevalence of hypertriglyceridemia than women (23.9% vs. 10.4%). The awareness of hypercholesterolemia in Koreans was higher in women than among men (62.4% vs. 51.4%). It increased with age; the level of awareness in participants 30 to 49 years of age (32.1% in men and 32.6% in women) was less than half of that observed among respondents ≥65 years old (77.5% in men and 78.0% in women). Regular check-ups for dyslipidemia and the active management thereof are urgent in Korean men aged 30 to 49. In women, the perimenopausal period is crucial for the prevention and management of metabolic syndrome, including dyslipidemia. Overall, improvements in awareness and treatment in the age group of 30 to 49 years in both men and women remain necessary.

Citations

Citations to this article as recorded by  
  • Association between plant-based diets and the risk of coronary heart disease predicted using the Framingham Risk Score in Korean men: data from the HEXA cohort study
    Khongorzul Ganbat, Bayarmaa Nasan Ulzii, Sangah Shin
    Epidemiology and Health.2024; 46: e2024035.     CrossRef
  • Association between weekend catch-up sleep and dyslipidemia among Korean workers
    Ye Seul Jang, Yu Shin Park, Kyungduk Hurh, Eun-Cheol Park, Sung-In Jang
    Scientific Reports.2023;[Epub]     CrossRef
  • The association between meat intake and the risk of coronary heart disease in Korean men using the Framingham risk score: A prospective cohort study
    Jiwon Jeong, Kyungjoon Lim, Sangah Shin
    Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(6): 1158.     CrossRef
  • New-onset dyslipidemia in adult cancer survivors from medically underserved areas: a 10-year retrospective cohort study
    Yun Hwa Jung, IL Yun, Eun-Cheol Park, Sung-In Jang
    BMC Cancer.2023;[Epub]     CrossRef
  • A Paradigm Shift in Dyslipidemia Management in Primary Care: A 12-Month Cohort Study
    Jun Hwa Hong, Ung Jeon, Won-Yong Shin, Weon Kim, Kayeon Seong, Sang-Ho Park, Hee-dong Kim, Joong-Wha Chung, Jaehyuk Choi
    Clinical Therapeutics.2022; 44(5): 698.     CrossRef
  • Temporal trends in heart failure over 11 years in the aging Korean population: A retrospective study using the national health insurance database
    Dong-Hyuk Cho, Chan Joo Lee, Jung-Woo Son, Jimi Choi, Jinseub Hwang, Byung-Su Yoo, Yajing Wang
    PLOS ONE.2022; 17(12): e0279541.     CrossRef
  • Cardiovascular risk and undertreatment of dyslipidemia in lung cancer survivors: A nationwide population-based study
    In Young Cho, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, Dong Woog Yoon, Sujeong Shin, Su-Min Jeong, Jong Ho Cho
    Current Problems in Cancer.2021; 45(1): 100615.     CrossRef
  • Association Between Blood Heavy Metal Concentrations and Dyslipidemia in the Elderly
    Xingmeng Zhu, Yong Fan, Jie Sheng, Ling Gu, Qi Tao, Rui Huang, Kaiyong Liu, Linsheng Yang, Guimei Chen, Hongjuan Cao, Kaichun Li, Fangbiao Tao, Sufang Wang
    Biological Trace Element Research.2021; 199(4): 1280.     CrossRef
  • The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a cross-sectional survey
    Jamaan Al-Zahrani, Mamdouh M. Shubair, Sameer Al-Ghamdi, Abdullah A. Alrasheed, Abdulrahman A. Alduraywish, Fayez Saud Alreshidi, Saeed Mastour Alshahrani, Majid Alsalamah, Badr F. Al-Khateeb, Aljawharah Ibraheem Ashathri, Ashraf El-Metwally, Khaled K. Al
    BMC Cardiovascular Disorders.2021;[Epub]     CrossRef
  • Prevalence, awareness, treatment, and control of dyslipidemia among diabetes mellitus patients and predictors of optimal dyslipidemia control: results from the Korea National Health and Nutrition Examination Survey
    Seung Jae Kim, Oh. Deog Kwon, Kyung-Soo Kim
    Lipids in Health and Disease.2021;[Epub]     CrossRef
  • Case Report of a Patient Diagnosed with Fatty Liver Accompanied by Hypertriglyceridemia
    Soyoung Hur, Soyeon An, Eujin Kim, Cho-Hyun Hwang, Eungyeong Jang, Youngchul Kim, Jang-Hoon Lee
    The Journal of Internal Korean Medicine.2021; 42(2): 207.     CrossRef
  • Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies)
    G. V. Artamonova, S. A. Maksimov, D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, T. A. Mulerova, E. B. Shapovalova, A. S. Agienko, O. V. Nakhratova, O. L. Barbarash
    Rational Pharmacotherapy in Cardiology.2021; 17(3): 362.     CrossRef
  • Pre-existing Depression among Newly Diagnosed Dyslipidemia Patients and Cardiovascular Disease Risk
    Jihoon Andrew Kim, Seulggie Choi, Daein Choi, Sang Min Park
    Diabetes & Metabolism Journal.2020; 44(2): 307.     CrossRef
  • Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
    Ye Seul Yang, Bo Ram Yang, Mi-Sook Kim, Yunji Hwang, Sung Hee Choi
    Lipids in Health and Disease.2020;[Epub]     CrossRef
  • Risk factors for cardiovascular disease in ethnic Europeans and Koreans living in the Primorsky Krai
    D. Yu. Bogdanov, V. A. Nevzorova, V. B. Shumatov, E. A. Kondrashova, E. Yu. Shestopalov
    Cardiovascular Therapy and Prevention.2020; 19(1): 40.     CrossRef
  • Effect of Smartphone-Based Lifestyle Coaching App on Community-Dwelling Population With Moderate Metabolic Abnormalities: Randomized Controlled Trial
    So Mi Jemma Cho, Jung Hyun Lee, Jee-Seon Shim, Hyungseon Yeom, Su Jin Lee, Yong Woo Jeon, Hyeon Chang Kim
    Journal of Medical Internet Research.2020; 22(10): e17435.     CrossRef
  • Risk factors for cardiovascular disease in ethnic Europeans and Koreans living in the Primorsky Krai
    D. Yu. Bogdanov, V. A. Nevzorova, V. B. Shumatov, E. A. Kondrashova, E. Yu. Shestopalov
    Cardiovascular Therapy and Prevention.2020; 19(1): 40.     CrossRef
  • The effect of healthy Nordic diet on cardio-metabolic markers: a systematic review and meta-analysis of randomized controlled clinical trials
    Nahid Ramezani-Jolfaie, Mohammad Mohammadi, Amin Salehi-Abargouei
    European Journal of Nutrition.2019; 58(6): 2159.     CrossRef
  • Association between Low-Intensity Smoking and Metabolic Syndrome in Korean Men
    Minji Park, Seran Min, Yu Jin Cho, Sunwoo Kim, Hyuktae Kwon, Hee-Kyung Joh, Bumjo Oh, Seung-Won Oh, Ho Chun Choi, Cheol Min Lee
    Journal of the Korean Society for Research on Nicotine and Tobacco.2019; 10(2): 89.     CrossRef
  • Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
    Chang-Wook Nam, Dong-Soo Kim, Jianyong Li, Marie T. Baccara-Dinet, Ivy Li, Ji-Hyun Kim, Chong-Jin Kim
    The Korean Journal of Internal Medicine.2019; 34(6): 1252.     CrossRef
  • Progress of Short-term Herbal Medicine Administration for Hypertriglyceridemia: a Case Report
    Bo-min Kim, Hee-geun Jo
    The Journal of Internal Korean Medicine.2019; 40(3): 517.     CrossRef
  • Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
    Nam Hoon Kim, Ki Hoon Han, Jimi Choi, Juneyoung Lee, Sin Gon Kim
    BMJ.2019; : l5125.     CrossRef
  • The risk of herpes zoster virus infection in patients with depression
    Hyo Geun Choi, Eui-Joong Kim, Young Kyung Lee, Miyoung Kim
    Medicine.2019; 98(40): e17430.     CrossRef
  • Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults
    Su‐Min Jeong, Seulggie Choi, Kyuwoong Kim, Sung Min Kim, Gyeongsil Lee, Seong Yong Park, Yeon‐Yong Kim, Joung Sik Son, Jae‐Moon Yun, Sang Min Park
    Journal of the American Heart Association.2018;[Epub]     CrossRef
  • Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
    Woohyeun Kim, Yeonyee E. Yoon, Sung-Hee Shin, Jang-Whan Bae, Bum-Kee Hong, Soon Jun Hong, Ki Chul Sung, Seung Hwan Han, Weon Kim, Moo-Yong Rhee, Sang-Hyun Kim, Sang Eun Lee, Min Su Hyon, Gyo-Seung Hwang, Jang Won Son, Jang-Young Kim, Min Kyu Kim, Sang Woo
    Clinical Therapeutics.2018; 40(6): 993.     CrossRef
  • Prevalence of dyslipidemia among the population of a large region of Eastern Siberia and its association with sociodemographic and behavioral factors
    Yu. I. Grinshtein, V. V. Shabalin, R. R. Ruf, M. M. Petrova, S. A. Shal'nova
    Profilakticheskaya meditsina.2018; 21(5): 63.     CrossRef
Close layer
The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
Young-Ah Moon
Endocrinol Metab. 2017;32(1):6-10.   Published online January 19, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.6
  • 10,161 View
  • 246 Download
  • 86 Web of Science
  • 83 Crossref
AbstractAbstract PDFPubReader   

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance, obesity, and dyslipidemia. NAFLD encompasses a wide range of states from the simple accumulation of triglycerides in the hepatocytes to serious states accompanied by inflammation and fibrosis in the liver. De novo lipogenesis has been shown to be a significant factor in the development of hepatic steatosis in insulin-resistant states. Sterol regulatory element binding protein-1c (SREBP-1c) is the main transcription factor that mediates the activation of lipogenesis, and SREBP cleavage activating protein (SCAP) is required for the activation of SREBPs. Here, recent animal studies that suggest SCAP as a therapeutic target for hepatic steatosis and hypertriglyceridemia are discussed.

Citations

Citations to this article as recorded by  
  • Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase
    Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar
    Molecular and Cellular Endocrinology.2025; 595: 112404.     CrossRef
  • Cholesterol Depletion Activate Hepatic Stellate Cells Mediated Through SREBP‐2 Signaling
    Nivya Vijayan, Madan Kumar Perumal
    Journal of Cellular Physiology.2025;[Epub]     CrossRef
  • The mechanism of DEHP-induced lipid accumulation in liver of female zebrafish
    Yueyue Mi, Jiamin Shi, Xuan Ma, Dongqiong Wei, Rongjian Liu, Samra, Cong Yuan, Yongmei Qi, Dejun Huang
    Environmental Pollution.2025; 366: 125455.     CrossRef
  • Cepharanthine relieves nonalcoholic steatohepatitis through inhibiting STAT1/CXCL10 axis-mediated lipogenesis and inflammatory responses
    Pan Li, Ruoyu Zhang, Pingping Hu, Tingting Wang, Jianwei Wang
    Journal of Ethnopharmacology.2025; 341: 119358.     CrossRef
  • Ergosterol alleviates hepatic steatosis and insulin resistance via promoting fatty acid β-oxidation by activating mitochondrial ACSL1
    Zu-Guo Zheng, Yi-Ping Zhang, Xiao-Yu Zhang, Meng-Yao Qin, Yin-Yue Xu, He Wu, Run-Qing Liu, Qiu-Yi Wu, Ming-Su Wang, Chong Zhang, Yue-Qin Zheng, Jian-Ye Dai, Ping Li, Hua Yang
    Cell Reports.2025; 44(1): 115203.     CrossRef
  • Dietary Methionine Hydroxy Analog Regulates Hepatic Lipid Metabolism via SIRT1/AMPK Signaling Pathways in Largemouth Bass Micropterus salmodies
    Ju Zhao, Zhongjie Yang, Haifeng Liu, Chao Yang, Yujun Chen, Quanquan Cao, Jun Jiang
    Biology.2025; 14(3): 227.     CrossRef
  • SREBPs as the potential target for solving the polypharmacy dilemma
    Xue Wang, Yanqiu Chen, Heyu Meng, Fanbo Meng
    Frontiers in Physiology.2024;[Epub]     CrossRef
  • The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis
    Preethi Chandrasekaran, Ralf Weiskirchen
    International Journal of Molecular Sciences.2024; 25(2): 1109.     CrossRef
  • Expression and correlation analysis of silent information regulator 1 (SIRT1), sterol regulatory element-binding protein-1 (SREBP1), and pyroptosis factor in gestational diabetes mellitus
    Ning Han, Xin-yuan Chang, Zi-li Yuan, Yi-zhan Wang
    The Journal of Maternal-Fetal & Neonatal Medicine.2024;[Epub]     CrossRef
  • Uxi (Endopleura uchi (Huber) Cuatrec) bark extract mitigates HFD-induced adiposity in rats via targeting oxidative stress, and lipogenic genes expression
    Eman A.R. Abdelghffar, Zuhair M. Mohammedsaleh, Raha Osailan, Aisha Elaimi, Wafae Ouchari, Mohamed A.O. Abdelfattah, Mona F. Mahmoud, Mansour Sobeh
    Journal of Functional Foods.2024; 114: 106034.     CrossRef
  • Robinetin Alleviates Metabolic Failure in Liver through Suppression of p300-CD38 Axis
    Ji-Hye Song, Hyo-Jin Kim, Jangho Lee, Seung-Pyo Hong, Min-Yu Chung, Yu-Geun Lee, Jae Ho Park, Hyo-Kyoung Choi, Jin-Taek Hwang
    Biomolecules & Therapeutics.2024; 32(2): 214.     CrossRef
  • Regeneration of Non-Alcoholic Fatty Liver Cells Using Chimeric FGF21/HGFR: A Novel Therapeutic Approach
    Sung-Jun Kim, So-Jung Kim, Jeongeun Hyun, Hae-Won Kim, Jun-Hyeog Jang
    International Journal of Molecular Sciences.2024; 25(6): 3092.     CrossRef
  • Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH
    Deqiang Zhang, Yuee Zhao, Gary Zhang, Daniel Lank, Sarah Cooke, Sujuan Wang, Alli Nuotio-Antar, Xin Tong, Lei Yin
    Molecular Metabolism.2024; 85: 101957.     CrossRef
  • Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications
    Lidianys María Lewis Lujan, Mark F. McCarty, Juan Carlos Galvez Ruiz, Sergio Trujillo Lopez, Simon Bernard Iloki-Assanga
    Human Nutrition & Metabolism.2024; 37: 200281.     CrossRef
  • Ubiquitination and De-Ubiquitination in the Synthesis of Cow Milk Fat: Reality and Prospects
    Rui Gao, Yanni Wu, Yuhao Wang, Zhangping Yang, Yongjiang Mao, Yi Yang, Chunhua Yang, Zhi Chen
    Molecules.2024; 29(17): 4093.     CrossRef
  • Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways
    Aneta Stachowicz, Klaudia Czepiel, Anna Wiśniewska, Kamila Stachyra, Magdalena Ulatowska-Białas, Beata Kuśnierz-Cabala, Marcin Surmiak, Grzegorz Majka, Katarzyna Kuś, Mark E. Wood, Roberta Torregrossa, Matthew Whiteman, Rafał Olszanecki
    Pharmacological Research.2024; 209: 107428.     CrossRef
  • Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c
    Wenjun Zhao, Xiaoying Wang, Wenlong Nie, Min Jiang, Yuan Zhao, Tong Zhang, Yue Ding
    Phytomedicine.2024; 134: 156017.     CrossRef
  • Evolutionary analysis of buffalo sterol regulatory element-binding factor (SREBF) family genes and their affection on milk traits
    Tingzhu Ye, Jing Yuan, Sayed Haidar Abbas Raza, Tingxian Deng, Lv Yang, Muhammad Jamil Ahmad, Seyed Mahdi Hosseini, Xinxin Zhang, Muna O Alamoudi, Qwait AlGabbani, Youssef S Alghamdi, Chao Chen, Aixin Liang, Nicola M. Schreurs, Liguo Yang
    Animal Biotechnology.2023; 34(7): 2082.     CrossRef
  • Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell Lines
    Machi Kanna, Yusuke Nakatsu, Takeshi Yamamotoya, Akifumi Kushiyama, Midori Fujishiro, Hideyuki Sakoda, Hiraku Ono, Koji Arihiro, Tomoichiro Asano
    International Journal of Molecular Sciences.2023; 24(10): 8847.     CrossRef
  • Dietary acetate promotes growth and nutrients deposition in Nile tilapia (Oreochromis niloticus) through increasing acetyl-CoA-triggered energy production
    Wen-Hao Zhou, Samwel M. Limbu, Yuan Luo, Rui-Xin Li, Jiong Ren, Fang Qiao, Mei-Ling Zhang, Zhen-Yu Du
    Aquaculture.2023; 575: 739750.     CrossRef
  • Palmitate로 유발된 비알코올성 지방간 세포 모델에서 블랙커런트 초임계 추출물의 지방증 개선효과
    수정 이, 은숙 양, 영호 김, 혜연 김, 혜란 최, 석 김, 태호 류
    Korean Journal of Food and Cookery Science.2023; 39(3): 178.     CrossRef
  • PM2.5 induced liver lipid metabolic disorders in C57BL/6J mice
    Chenxiao Zhang, Tengfei Ma, Chang Liu, Ding Ma, Jian Wang, Meng Liu, Jinjun Ran, Xueting Wang, Xiaobei Deng
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • High Gamma-Aminobutyric Acid (GABA) Oolong Tea Alleviates High-Fat Diet-Induced Metabolic Disorders in Mice
    Monthana Weerawatanakorn, Sang He, Chun-Han Chang, Yen-Chun Koh, Meei-Ju Yang, Min-Hsiung Pan
    ACS Omega.2023; 8(37): 33997.     CrossRef
  • MicroRNA-19a regulates milk fat metabolism by targeting SYT1 in bovine mammary epithelial cells
    Baojun Yu, Jiamin Liu, Zhengyun Cai, Tong Mu, Di Zhang, Xiaofang Feng, Yaling Gu, Juan Zhang
    International Journal of Biological Macromolecules.2023; 253: 127096.     CrossRef
  • SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies
    Na Li, Xiaodan Li, Yifu Ding, Xiao Liu, Karin Diggle, Tatiana Kisseleva, David A. Brenner
    Biomedicines.2023; 11(12): 3280.     CrossRef
  • Daidzein stimulates fatty acid-induced fat deposition in C2C12 myoblast cells via the G protein-coupled receptor 30 pathway
    Chengjian Zhou, Ping Li, Meihong Han, Xuejun Gao
    Animal Biotechnology.2022; 33(5): 851.     CrossRef
  • Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress
    Qichuang Liu, Maoyuan Mu, Huan Chen, Guoyuan Zhang, Yanqing Yang, Jun Chu, Ying Li, Fangwan Yang, Shide Lin
    Molecular and Cellular Biochemistry.2022; 477(11): 2481.     CrossRef
  • The cholesterol pathway: impact on immunity and cancer
    Ryan J. King, Pankaj K. Singh, Kamiya Mehla
    Trends in Immunology.2022; 43(1): 78.     CrossRef
  • Hepatic retinaldehyde dehydrogenases are modulated by tocopherol supplementation in mice with hepatic steatosis
    Amanda D'Espessailles, Valeria Campos, Nevenka Juretić, Gladys S. Tapia, Paulina Pettinelli
    Nutrition.2022; 94: 111539.     CrossRef
  • CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
    Han Zeng, Hong Qin, Meng Liao, Enze Zheng, Xiaoqing Luo, Anhua Xiao, Yiyu Li, Lin Chen, Li Wei, Lei Zhao, Xiong Z. Ruan, Ping Yang, Yaxi Chen
    Molecular Metabolism.2022; 57: 101428.     CrossRef
  • Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions
    Claudio M. Fader Kaiser, Patricia S. Romano, M. Cristina Vanrell, Cristian A. Pocognoni, Julieta Jacob, Benjamín Caruso, Laura R. Delgui
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, pl
    Neeta B Amin, Amanda Darekar, Quentin M Anstee, Vincent Wai-Sun Wong, Frank Tacke, Manoli Vourvahis, Douglas S Lee, Michael Charlton, Naim Alkhouri, Atsushi Nakajima, Carla Yunis
    BMJ Open.2022; 12(3): e056159.     CrossRef
  • Identification of microRNA Transcriptome Involved in Bovine Intramuscular Fat Deposition
    Susan K. Duckett, Maslyn A. Greene
    Frontiers in Veterinary Science.2022;[Epub]     CrossRef
  • Camellia (Camellia oleifera bel.) seed oil reprograms gut microbiota and alleviates lipid accumulation in high fat-fed mice through the mTOR pathway
    Jing Gao, Li Ma, Jie Yin, Gang Liu, Jie Ma, SiTing Xia, SaiMing Gong, Qi Han, TieJun Li, YongZhong Chen, YuLong Yin
    Food & Function.2022; 13(9): 4977.     CrossRef
  • The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Yuxian Yang, Shuting Li, Yuechao Xu, Jing Ke, Dong Zhao
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1505.     CrossRef
  • Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
    Yuanli Wang, Rulong Chen, Jingyi Li, Guodong Zeng, Juntao Yuan, Jingran Su, Chunyan Wu, Zhongbing Lu, Fang Zhang, Wenjun Ding
    Antioxidants.2022; 11(6): 1093.     CrossRef
  • Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis
    Satoshi Kawamura, Yuki Matsushita, Shigeyuki Kurosaki, Mizuki Tange, Naoto Fujiwara, Yuki Hayata, Yoku Hayakawa, Nobumi Suzuki, Masahiro Hata, Mayo Tsuboi, Takahiro Kishikawa, Hiroto Kinoshita, Takuma Nakatsuka, Masaya Sato, Yotaro Kudo, Yujin Hoshida, At
    Journal of Clinical Investigation.2022;[Epub]     CrossRef
  • Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation
    Pan Li, Ruoyu Zhang, Meng Wang, Yuwei Chen, Zhiwei Chen, Xiumei Ke, Ling Zuo, Jianwei Wang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Identification and validation of immune related core transcription factors GTF2I in NAFLD
    Minbo Zhang, Yu Zhang, Xiaoxiao Jiao, Linying Lai, Yiting Qian, Bo Sun, Wenzhuo Yang
    PeerJ.2022; 10: e13735.     CrossRef
  • Lipid-lowering effect of microencapsulated peptides from brewer's spent grain in high-sucrose diet-fed rats
    M.R. Ferreira, A.G. Garzón, M.E. Oliva, R.E. Cian, S.R. Drago, M.E. D'Alessandro
    Food Bioscience.2022; 49: 101981.     CrossRef
  • The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis
    Arwa Aldaalis, Maria T. Bengoechea-Alonso, Johan Ericsson
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Targets of statins intervention in LDL-C metabolism: Gut microbiota
    ChangXin Sun, ZePing Wang, LanQing Hu, XiaoNan Zhang, JiYe Chen, ZongLiang Yu, LongTao Liu, Min Wu
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs
    Shereen A. El Sobky, Nourhan K. Aboud, Nihal M. El Assaly, Injie O. Fawzy, Nada El-Ekiaby, Ahmed I. Abdelaziz
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
    Oelfah Patel, Christo J. F. Muller, Elizabeth Joubert, Bernd Rosenkranz, Johan Louw, Charles Awortwe
    Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
  • Capparis spinosa improves non-alcoholic steatohepatitis through down-regulating SREBP-1c and a PPARα-independent pathway in high-fat diet-fed rats
    Rasoul Akbari, Hamid Yaghooti, Mohammad Taha Jalali, Laya Sadat Khorsandi, Narges Mohammadtaghvaei
    BMC Research Notes.2022;[Epub]     CrossRef
  • Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways
    Shuhua Shen, Kungen Wang, Yihui Zhi, Yue Dong
    Pharmaceutical Biology.2022; 60(1): 1949.     CrossRef
  • CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4+ T cells in Sjogren’s syndrome
    Junhao Yin, Jiayao Fu, Yanxiong Shao, Jiabao Xu, Hui Li, Changyu Chen, Yijie Zhao, Zhanglong Zheng, Chuangqi Yu, Lingyan Zheng, Baoli Wang
    Clinical and Experimental Medicine.2022; 23(5): 1691.     CrossRef
  • Differential TM4SF5‐mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression
    Jihye Ryu, Eunmi Kim, Min‐Kyung Kang, Dae‐Geun Song, Eun‐Ae Shin, Haesong Lee, Jae Woo Jung, Seo Hee Nam, Ji Eon Kim, Hye‐Jin Kim, Taekwon Son, Semi Kim, Hwi Young Kim, Jung Weon Lee
    The Journal of Pathology.2021; 253(1): 55.     CrossRef
  • Changes in Glutathione Content in Liver Diseases: An Update
    Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Andrea Ferrigno, Clarissa Berardo
    Antioxidants.2021; 10(3): 364.     CrossRef
  • Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings
    Baris Akinci, Angela Subauste, Nevin Ajluni, Nazanene H. Esfandiari, Rasimcan Meral, Adam H. Neidert, Akin Eraslan, Rita Hench, Diana Rus, Barbara Mckenna, Hero K. Hussain, Thomas L. Chenevert, Marwan K. Tayeh, Amit R. Rupani, Jeffrey W. Innis, Christos S
    Med.2021; 2(7): 814.     CrossRef
  • Prediction of Srebp-1 as a Key Target of Qing Gan San Against MAFLD in Rats via RNA-Sequencing Profile Analysis
    Bendong Yang, Jingyue Sun, Shufei Liang, Peixuan Wu, Rui Lv, Yanping He, Deqi Li, Wenlong Sun, Xinhua Song
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake
    Miaoqing Hu, Fan Yang, Yawen Huang, Xin You, Desheng Liu, Shan Sun, Sen-Fang Sui
    Science Advances.2021;[Epub]     CrossRef
  • Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease
    Justin K. Murray, Jason Long, Lei Liu, Shivani Singh, Danielle Pruitt, Michael Ollmann, Elissa Swearingen, Miki Hardy, Oliver Homann, Bin Wu, Jerry Ryan Holder, Kelvin Sham, Brad Herberich, Mei-Chu Lo, Hui Dou, Artem Shkumatov, Monica Florio, Ingrid C. Ru
    Nucleic Acid Therapeutics.2021; 31(5): 324.     CrossRef
  • Molecular mechanism of DLBS3733, a bioactive fraction of Lagerstroemia speciosa (L.) Pers., on ameliorating hepatic lipid accumulation in HepG2 cells
    Olivia M. Tandrasasmita, Guntur Berlian, Raymond R. Tjandrawinata
    Biomedicine & Pharmacotherapy.2021; 141: 111937.     CrossRef
  • The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis
    Margaret Vourakis, Gaétan Mayer, Guy Rousseau
    International Journal of Molecular Sciences.2021; 22(15): 8074.     CrossRef
  • Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio
    Anna Wiśniewska, Aneta Stachowicz, Katarzyna Kuś, Magdalena Ulatowska-Białas, Justyna Totoń-Żurańska, Anna Kiepura, Kamila Stachyra, Maciej Suski, Mariusz Gajda, Jacek Jawień, Rafał Olszanecki
    International Journal of Molecular Sciences.2021; 22(19): 10688.     CrossRef
  • Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis
    Yu-Chi Chen, Rong-Jane Chen, Szu-Yuan Peng, Winston C. Y. Yu, Vincent Hung-Shu Chang
    Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
  • Regulation of Key Genes for Milk Fat Synthesis in Ruminants
    Tong Mu, Honghong Hu, Yanfen Ma, Xiaofang Feng, Juan Zhang, Yaling Gu
    Frontiers in Nutrition.2021;[Epub]     CrossRef
  • Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
    Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
  • Lipidomic profiling analysis of the phospholipid molecules in SCAP-induced lipid droplet formation in bovine mammary epithelial cells
    Liqiang Han, Kun Pang, Xiu ling Li, Juan J Loor, Guo yu Yang, Tengyun Gao
    Prostaglandins & Other Lipid Mediators.2020; 149: 106420.     CrossRef
  • Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
    Amedeo Lonardo, Ayako Suzuki
    Journal of Clinical Medicine.2020; 9(5): 1278.     CrossRef
  • Smurf1 aggravates non‐alcoholic fatty liver disease by stabilizing SREBP‐1c in an E3 activity‐independent manner
    Xin Zhang, Yutao Zhan, Wenjun Lin, Fei Zhao, Chaojing Guo, Yujiao Chen, Mengge Du, Dongnian Li, Lingqiang Zhang, Wei An, Hong‐Rui Wang, Ping Xie
    The FASEB Journal.2020; 34(6): 7631.     CrossRef
  • Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia
    Hyun-Jin An, Jung-Yeon Kim, Mi-Gyeong Gwon, Hyemin Gu, Hyun-Ju Kim, Jaechan Leem, Sung Won Youn, Kwan-Kyu Park
    International Journal of Molecular Sciences.2020; 21(2): 552.     CrossRef
  • Lack of Augmenter of Liver Regeneration Disrupts Cholesterol Homeostasis of Liver in Mice by Inhibiting the AMPK Pathway
    Xin Wang, Ling‐yue Dong, Qu‐jing Gai, Wei‐lun Ai, Yuan Wu, Wei‐chun Xiao, Jing Zhang, Wei An
    Hepatology Communications.2020; 4(8): 1149.     CrossRef
  • HESA-A Attenuates Hepatic Steatosis in NAFLD Rat Model Through the Suppression of SREBP-1c and NF-kβ
    M. Efati, M. Khorrami, Z. Jangravi, A. Z. Mahmoudabadi, M. Raeiszadeh, J. R. Sarshoori
    International Journal of Peptide Research and Therapeutics.2020; 26(3): 1283.     CrossRef
  • Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
    Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Huan Nie, Maoxing Pan, Runsen Chen, Jiqian Xie, Qinhe Yang, Yupei Zhang
    Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
  • (−)-Epicatechin and the comorbidities of obesity
    Eleonora Cremonini, Dario E. Iglesias, Jiye Kang, Giovanni E. Lombardo, Zahra Mostofinejad, Ziwei Wang, Wei Zhu, Patricia I. Oteiza
    Archives of Biochemistry and Biophysics.2020; 690: 108505.     CrossRef
  • microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
    Bernice Monchusi, Mandeep Kaur
    Genes & Cancer.2020; 11(1-2): 20.     CrossRef
  • Cellular acidosis triggers human MondoA transcriptional activity by driving mitochondrial ATP production
    Blake R Wilde, Zhizhou Ye, Tian-Yeh Lim, Donald E Ayer
    eLife.2019;[Epub]     CrossRef
  • Differential Recovery Speed of Activity and Metabolic Rhythms in Rats After an Experimental Protocol of Shift-Work
    Nadia Saderi, Adrián Báez-Ruiz, Lucia E. Azuara-Álvarez, Carolina Escobar, Roberto C. Salgado-Delgado
    Journal of Biological Rhythms.2019; 34(2): 154.     CrossRef
  • Genetically modified mouse models to study hepatic neutral lipid mobilization
    Guenter Haemmerle, Achim Lass
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019; 1865(5): 879.     CrossRef
  • Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism
    Elham Karimi-Sales, Abbas Ebrahimi-Kalan, Mohammad Reza Alipour
    Biomedicine & Pharmacotherapy.2019; 109: 1306.     CrossRef
  • A new pathway to eSCAPe lipotoxicity
    Fadila Benhamed, Catherine Postic
    Clinics and Research in Hepatology and Gastroenterology.2018; 42(1): 3.     CrossRef
  • Overexpression of SREBF chaperone (SCAP) enhances nuclear SREBP1 translocation to upregulate fatty acid synthase (FASN) gene expression in bovine mammary epithelial cells
    L.Q. Han, T.Y. Gao, G.Y. Yang, J.J. Loor
    Journal of Dairy Science.2018; 101(7): 6523.     CrossRef
  • Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
    Gyuri Kim, Suk-Yong Jang, Chung Mo Nam, Eun Seok Kang
    Journal of Hepatology.2018; 68(3): 476.     CrossRef
  • Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD)
    Dominika Maciejewska, Wojciech Marlicz, Karina Ryterska, Marcin Banaszczak, Dominika Jamioł-Milc, Ewa Stachowska
    Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
  • Systems Analysis of the Liver Transcriptome in Adult Male Zebrafish Exposed to the Plasticizer (2-Ethylhexyl) Phthalate (DEHP)
    Matthew Huff, Willian A. da Silveira, Oliana Carnevali, Ludivine Renaud, Gary Hardiman
    Scientific Reports.2018;[Epub]     CrossRef
  • Inactivation of ceramide synthase 2 catalytic activity in mice affects transcription of genes involved in lipid metabolism and cell division
    Andreas Bickert, Paul Kern, Martina van Uelft, Stefanie Herresthal, Thomas Ulas, Katharina Gutbrod, Bernadette Breiden, Joachim Degen, Konrad Sandhoff, Joachim L. Schultze, Peter Dörmann, Dieter Hartmann, Reinhard Bauer, Klaus Willecke
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2018; 1863(7): 734.     CrossRef
  • Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet–Induced Hepatic Steatosis in Mice
    Ian Huck, Kevin Beggs, Udayan Apte
    International Journal of Toxicology.2018; 37(5): 383.     CrossRef
  • Developmental and extrahepatic physiological functions of SREBP pathway genes in mice
    Luke J. Engelking, Mary Jo Cantoria, Yanchao Xu, Guosheng Liang
    Seminars in Cell & Developmental Biology.2018; 81: 98.     CrossRef
  • Herbacetin, a flaxseed flavonoid, ameliorates high percent dietary fat induced insulin resistance and lipid accumulation through the regulation of hepatic lipid metabolizing and lipid-regulating enzymes
    Chinnadurai Veeramani, Mohammed A. Alsaif, Khalid S. Al-Numair
    Chemico-Biological Interactions.2018; 288: 49.     CrossRef
  • Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
    Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, Lutgarda Bozzetto, Giovanni Annuzzi, Angela Rivellese
    Nutrients.2017; 9(10): 1065.     CrossRef
  • MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice
    Xu Wang, Linlin Shi, Sun Joyce, Yuan Wang, Yi Feng
    International Journal of Molecular Sciences.2017; 18(9): 1930.     CrossRef
Close layer
Original Articles
Obesity and Metabolism
Increased Risk of Diabetes Development in Subjects with the Hypertriglyceridemic Waist Phenotype: A 4-Year Longitudinal Study
Ki Joong Han, Shin Yeoung Lee, Nam Hee Kim, Hyun Beom Chae, Tae Hoon Lee, Choel Min Jang, Kyung Mo Yoo, Hae Jung Park, Min Kyung Lee, Won Seon Jeon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinol Metab. 2014;29(4):514-521.   Published online December 29, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.4.514
  • 6,086 View
  • 30 Download
  • 21 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   
Background

The hypertriglyceridemic waist (HTGW) phenotype is a simple and inexpensive screening parameter to identify people at increased risk of cardiovascular disease. We evaluated whether the HTGW phenotype predicts diabetes in urban Korean adults.

Methods

A total of 2,900 nondiabetic subjects (mean age 44.3 years), comprising 2,078 males (71.7%) and 822 females (28.3%) who underwent annual medical check-ups at our center between January 2005 and December 2009, were recruited. The subjects were divided into four groups according to baseline serum triglyceride (TG) level and waist circumference (WC): normal WC-normal TG (NWNT) level, normal WC-high TG level, enlarged WC-normal TG level, and enlarged WC-high TG (EWHT) level. High serum TG level was defined as ≥150 mg/dL and enlarged WC was defined as ≥90 cm for men and ≥85 cm for women. New cases of diabetes were determined according to questionnaires filled in by participants and the diagnostic criteria of the American Diabetes Association. Cox proportional hazards model analysis was used to assess the association of HTGW phenotype with the incidence of diabetes.

Results

A total of 101 (3.5%) new diabetes cases were diagnosed during the study period. The EWHT group had a higher incidence of diabetes (8.3%) compared with the NWNT group (2.2%). The adjusted hazard ratio for diabetes for subjects with the EWHT phenotype at baseline was 4.113 (95% confidence interval [CI], 2.397 to 7.059) after adjustment for age, and 2.429 (95% CI, 1.370 to 4.307) after adjustment for age, sex, total cholesterol, systolic blood pressure, and alcohol drinking history. It was attenuated by inclusion of baseline fasting glucose level in the model.

Conclusion

Subjects with the HTGW phenotype showed the highest risk of incident diabetes. This tool could be useful for identifying individuals at high risk of diabetes.

Citations

Citations to this article as recorded by  
  • Triglyceridemic Waist Phenotypes as Risk Factors for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Fiorella E. Zuzunaga-Montoya, Víctor Juan Vera-Ponce
    International Journal of Statistics in Medical Research.2024; 13: 19.     CrossRef
  • Association between hypertriglyceridemic-waist phenotype and circadian syndrome risk: a longitudinal cohort study
    Li-Kun Hu, Yu-Hong Liu, Kun Yang, Ning Chen, Lin-Lin Ma, Yu-Xiang Yan
    Hormones.2023; 22(3): 457.     CrossRef
  • Caracterización del fenotipo de cintura hipertrigliceridémica en pacientes con diabetes mellitus tipo 2 en España: un estudio epidemiológico
    I. Miñambres, J. Sánchez-Hernández, G. Cuixart, A. Sánchez-Pinto, J. Sarroca, A. Pérez
    Revista Clínica Española.2021; 221(10): 576.     CrossRef
  • Association of “hypertriglyceridemic waist” with increased 5-year risk of subclinical atherosclerosis in a multi-ethnic population: a prospective cohort study
    Peyman Namdarimoghaddam, Adeleke Fowokan, Karin H. Humphries, G. B. John Mancini, Scott Lear
    BMC Cardiovascular Disorders.2021;[Epub]     CrossRef
  • Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study
    I. Miñambres, J. Sánchez-Hernandez, G. Cuixart, A. Sánchez-Pinto, J. Sarroca, A. Pérez
    Revista Clínica Española (English Edition).2021; 221(10): 576.     CrossRef
  • Association between Hypertriglyceridemic-Waist Phenotype and Risk of Type 2 Diabetes Mellitus in Middle-Aged and Older Chinese Population: A Longitudinal Cohort Study
    Dezhong Chen, Ziyun Liang, Huimin Sun, Ciyong Lu, Weiqing Chen, Harry H. X. Wang, Vivian Yawei Guo
    International Journal of Environmental Research and Public Health.2021; 18(18): 9618.     CrossRef
  • Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women
    Yujuan Xiang, Wenzhong Zhou, Xuening Duan, Zhimin Fan, Shu Wang, Shuchen Liu, Liyuan Liu, Fei Wang, Lixiang Yu, Fei Zhou, Shuya Huang, Liang Li, Qiang Zhang, Qinye Fu, Zhongbing Ma, Dezong Gao, Shude Cui, Cuizhi Geng, Xuchen Cao, Zhenlin Yang, Xiang Wang,
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Hypertriglyceridemic Waist Phenotype and Lipid Accumulation Product: Two Comprehensive Obese Indicators of Waist Circumference and Triglyceride to Predict Type 2 Diabetes Mellitus in Chinese Population
    Minrui Xu, Mingtao Huang, Deren Qiang, Jianxin Gu, Yong Li, Yingzi Pan, Xingjuan Yao, Wenchao Xu, Yuan Tao, Yihong Zhou, Hongxia Ma, Ulrike Rothe
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Prevalence and relationship of hypertriglyceridaemic–waist phenotype and type 2 diabetes mellitus among a rural adult Chinese population
    Yong-Cheng Ren, Yu Liu, Xi-Zhuo Sun, Bing-Yuan Wang, Yi Liu, Hu Ni, Yang Zhao, Dechen Liu, Xuejiao Liu, Dongdong Zhang, Feiyan Liu, Cheng Cheng, Leilei Liu, Xu Chen, Qionggui Zhou, Ming Zhang, Dongsheng Hu
    Public Health Nutrition.2019; 22(8): 1361.     CrossRef
  • Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis
    Chun-Ming Ma, Xiao-Li Liu, Na Lu, Rui Wang, Qiang Lu, Fu-Zai Yin
    Endocrine.2019; 64(3): 469.     CrossRef
  • Superior Role of Waist Circumference to Body-Mass Index in the Prediction of Cardiometabolic Risk in Dyslipidemic Patients
    Ľ. Cibičková, K. Langová, H. Vaverková, J. Lukeš, N. Cibiček
    Physiological Research.2019; : 931.     CrossRef
  • Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
    Eun-Jung Rhee
    Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
  • Letter: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
    Eun-Jung Rhee
    Endocrinology and Metabolism.2017; 32(3): 396.     CrossRef
  • The Relationship between Hypertriglyceridemic Waist Phenotype and Early Diabetic Nephropathy in Type 2 Diabetes
    Chun-Ming Ma, Rui Wang, Xiao-Li Liu, Na Lu, Qiang Lu, Fu-Zai Yin
    Cardiorenal Medicine.2017; 7(4): 295.     CrossRef
  • The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population
    Jing Zeng, Miao Liu, Lei Wu, Jianhua Wang, Shanshan Yang, Yiyan Wang, Yao Yao, Bin Jiang, Yao He
    International Journal of Environmental Research and Public Health.2016; 13(12): 1233.     CrossRef
  • Prevalence of hypertriglyceridemic waist and association with risk of type 2 diabetes mellitus: a meta‐analysis
    Yongcheng Ren, Xinping Luo, Chongjian Wang, Lei Yin, Chao Pang, Tianping Feng, Bingyuan Wang, Lu Zhang, Linlin Li, Xiangyu Yang, Hongyan Zhang, Jingzhi Zhao, Dongsheng Hu
    Diabetes/Metabolism Research and Reviews.2016; 32(4): 405.     CrossRef
  • Utility of hypertriglyceridemic waist phenotype for predicting incident type 2 diabetes: The Isfahan Diabetes Prevention Study
    Mohsen Janghorbani, Masoud Amini
    Journal of Diabetes Investigation.2016; 7(6): 860.     CrossRef
  • βig-h3 Represses T-Cell Activation in Type 1 Diabetes
    Maeva Patry, Romain Teinturier, Delphine Goehrig, Cornelia Zetu, Doriane Ripoche, In-San Kim, Philippe Bertolino, Ana Hennino
    Diabetes.2015; 64(12): 4212.     CrossRef
  • Hypertriglyceridemic Waist – a Simple Clinical Tool to Detect Cardiometabolic Risk: Comparison With Harmonized Definition of Metabolic Syndrome
    H. VAVERKOVÁ, D. KARÁSEK, D. NOVOTNÝ, M. HALENKA, J. ORSÁG, L. SLAVÍK
    Physiological Research.2015; : S385.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes
    Seung-Hwan Lee, Hae Kyung Yang, Hee-Sung Ha, Jin-Hee Lee, Hyuk-Sang Kwon, Yong-Moon Park, Hyeon-Woo Yim, Moo-Il Kang, Won-Chul Lee, Ho-Young Son, Kun-Ho Yoon
    Medicine.2015; 94(40): e1705.     CrossRef
Close layer
APOA5 Polymorphism Is Associated with Metabolic Syndrome in Korean Postmenopausal Women.
Doh Hee Kim, Seung Hee Lee, Kyung Hoon Han, Chae Bong Kim, Kwan Young Song, Sook Cho, Kye Heui Lee
Endocrinol Metab. 2012;27(4):276-281.   Published online December 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.4.276
  • 5,243 View
  • 24 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Menopause is an independent risk factor in metabolic syndrome which induced an alteration of the lipid metabolism by hormonal changes. Apolipoprotein A5 gene (APOA5) was related to the regulation of triglyceride and high density lipoprotein cholesterol (HDL-C) level with biosynthesis and decomposition. This study was conducted to investigate the relationship between APOA5 polymorphism and metabolic syndrome in Korean postmenopausal women. METHODS: This study included 307 postmenopausal women with anthropometric and biochemical measurement in 2010-2011. The polymorphism of APOA5 was analyzed by polymerase chain reaction-restriction fragment length polymorphism method with MseI restriction enzyme. RESULTS: The metabolic syndrome prevalence with TT genotype was significantly lower than the frequency in those with TC/CC (27.09%, 38.46%, and 45.71% for TT, TC, and CC, respectively; P < 0.05). Multiple regression analysis of metabolic syndrome risk factors indicated that postmenopausal women with CC genotype had a higher risk with 3 times than that in TT genotype (P < 0.05). APOA5 C carriers showed an increased risk of triglyceride level (odd ratio, 2.93 and 1.85 for CC and TC+CC, respectively; P < 0.05). Interestingly, HDL-C was related to triglyceride directly in comparison to APOA5. CONCLUSION: The results of this study indicate that APOA5 has an influence on serum triglyceride and HDL-C, which contribute to metabolic syndrome in Korean postmenopausal women.

Citations

Citations to this article as recorded by  
  • Effects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism
    Minjoo Kim, Jey Sook Chae, Miri Kim, Sang-Hyun Lee, Jong Ho Lee
    Nutrition Journal.2014;[Epub]     CrossRef
  • APOA5Polymorphism Is Associated with Metabolic Syndrome in Korean Postmenopausal Women
    Mi Hae Seo, Won Young Lee
    Endocrinology and Metabolism.2012; 27(4): 274.     CrossRef
Close layer
Case Report
Ketoacidosis with Hypertriglyceridemia-Induced Pancreatitis in a Patient with Gestational Diabetes: A Case Report.
Hyun Hee Chung, Sang Hyun Park, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
Endocrinol Metab. 2012;27(1):89-92.   Published online March 1, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.1.89
  • 2,621 View
  • 23 Download
  • 3 Crossref
AbstractAbstract PDF
Hypertriglyceridemia-induced acute pancreatitis in pregnancy is not a common complication. Moreover, ketoacidosis in gestational diabetes occurs rarely. Here we report a case of ketoacidosis with hypertriglyceridemia-induced pancreatitis in a patient with gestational diabetes that was successfully treated with insulin and supportive care. In this case, a 36-year-old woman (at 32 weeks' gestation) was diagnosed with gestational diabetes 4 weeks prior, but did not have well controlled blood sugar. She complained of severe epigastric pain concomitant with nausea and vomiting. Radiology and laboratory tests found hypertriglyceridemia (1,996 mg/dL), acute pancreatitis, and ketoacidosis with absence of fetal deceleration on a non-stress test. The patient's condition improved with insulin therapy and fluid replacement. To our knowledge, this is the first report of a case of ketoacidosis with hypertriglyceridemia-induced pancreatitis in a patient with gestational diabetes.

Citations

Citations to this article as recorded by  
  • Acute Pancreatitis in a Pregnant Patient with Type IV Hyperlipoproteinemia
    Sang Ho Lee, Jae Hyuck Jun, Young Seok Doh, Ji Woong Jang, Sae Hee Kim, Il Hyun Baek, Sung Hee Jung
    The Korean Journal of Pancreas and Biliary Tract.2019; 24(2): 73.     CrossRef
  • Hypertriglyceridemia-Induced Acute Pancreatitis
    Jin Myung Park
    The Korean Journal of Pancreas and Biliary Tract.2017; 22(4): 158.     CrossRef
  • Cheese-like Material in the Heart: An Autopsy Case Report of Severe Hypertriglyceridemia in Diabetic Ketoacidosis Patient
    Joo Young Na, Eun Hee Kim, Bon Young Koo, Ik Jo Chung, Byung Ha Choi, Nak Eun Chung
    Korean Journal of Legal Medicine.2013; 37(4): 212.     CrossRef
Close layer
Original Article
Free T4 is Negatively Correlated with Non-alcoholic Fatty Liver Disease in Euthyroid Women.
Eon Ju Jun, Hyun Sook Kim, Hyue Kyung Chung, Ji Hyun Lee, Sae Rom Kim, Eui Dal Jung
J Korean Endocr Soc. 2009;24(2):87-92.   Published online June 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.2.87
  • 2,224 View
  • 20 Download
AbstractAbstract PDF
BACKGROUND
Thyroid hormones play an important role in the regulation of lipid and carbohydrate metabolism and the body mass index (BMI), which all affect non-alcoholic fatty liver disease (NAFLD). In a previous study, we demonstrated that free T4 was negatively associated with the BMI in euthyroid women. However, there is still uncertain as to whether the thyroid function within the normal range is associated with NAFLD and liver function abnormalities. We sought to evaluate the thyroid function (free T4, TSH) and its possible relationship with NAFLD in euthyroid women. METHODS: A total of 835 euthyroid, non heavy alcoholics women who visited the Daegu Catholic University University Medical Centre for primary health screening from January 1, 2006 to December 31, 2006 participated in this cross-sectional study. The women who were not euthyroid or heavy alcoholics (> 70 g/week in women according to the DSM-IV), there was no known history of diabetes mellitus, the fasting blood glucose was more than 5.55 mmol/L and those who had viral hepatitis were excluded. Hepatic ultrasonography scanning was performed in all the participants by a single experienced radiologist. The TSH, free T4, BP, fasting glucose, serum liver enzymes (AST, ALT, GGT, T-bilirubin), lipid profiles [total-cholesterol, triglyceride (TG), HDL-C, LDL-C] and NAFLD were evaluated. RESULTS: Euthyroid women with NAFLD had lower free T4 levels than did the euthyroid women without NAFLD. After adjustment for age and BMI, free T4 was negatively correlated with TG, but free T4 was positively correlated with the total serum bilirubin. Free T4 was not correlated with the serum AST, ALT and GGT. After adjustment for age, the BMI, the fasting glucose, the GGT and free T4, but not TSH, were significantly negatively correlated with NAFLD. CONCLUSION: We demonstrated a negative correlation between free T4 and NAFLD in euthyroid women. This finding suggests lower levels of free T4 is associated with NAFLD in euthyroid subjects.
Close layer
Case Report
A Case of Acute Pancreatitis and Severe Hypertriglyceridemia Associated with Clozapine.
Hye Kyeong Park, Hye Jin Won, Hyo Seung Ahn, Ban Suk Lee, Seung Gu Kim, Woo Je Lee, Kyung Soo Ko, Byoung Doo Rhee
J Korean Endocr Soc. 2007;22(5):381-385.   Published online October 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.5.381
  • 2,286 View
  • 26 Download
AbstractAbstract PDF
Clozapine, an atypical antipsychotic agent, has been linked to several cases of acute pancreatitis and hypertriglyceridemia. However, neither acute pancreatitis nor hypertriglyceridemia associated with clozapine has yet been reported in the Republic of Korea. Based on recent experience, we report on a case of severe hypertriglyceridemia and acute pancreatitis associated with clozapine. A 37-year-old schizophrenic woman in good physical condition presented with abdominal pain of acute onset. She had been taking clozapine for 20 months to control her schizophrenia. On admission, her serum triglyceride level was 6,670 mg/dL. Elevated serum amylase and lipase levels, as well as abdominal computed tomography findings, were compatible with acute pancreatitis. After discontinuing the use of clozapine, the serum triglyceride level was normalized and acute pancreatitis resolved.
Close layer
Original Article
Lipid Profile Changes in Postmenopausal Korean Women Treated with Alendronate (10 mg) for 2 Years: Comparing with Control Group.
Il Woo Joo, Han Jin Oh
J Korean Endocr Soc. 2007;22(1):19-25.   Published online February 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.1.19
  • 2,423 View
  • 21 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Bisphosphonate, which has been used for prevention and treatment of osteoporosis with the mechanism of inhibiting bone resorption, also has an association with the cholesterol synthethic process. This suggests that bisphosphonate might have benefit to improve the lipid profile in humans through a process that blocks the mevalonate-squalene pathway. However, few reports have revealed the relationship between the action of bisphosphonate and lipid metabolism in postmenopausal Korean women. We planned this study to determine the effect of alendronate (10 mg) on the serum lipid level in postmenopausal Korean women. Subjects and METHODS: We retrospectively evaluated the postmenopausal Korean women (aged over 50) who visited the Osteoporosis clinic in the Health Care Center in Seoul from March of 2003 to October of 2005. The changes of the serum lipid levels, including total cholesterol, triglyceride, and HDL cholesterol, after 2-years of alendronate 10 mg administration were evaluated and comparing to a control group. RESULTS: After 2-years alendronate (10 mg) administration, the total cholesterol was decreased by 11.8 +/- 3.7 mg/dL, and the HDL cholesterol was increased by 5.2 +/-1.4 mg/dL as compared to the baseline lipid level. Both of these results showed statistical significance. Changes of the triglyceride and fasting blood glucose also showed a decline by 15.4 +/-9.8 mg/dL and 6.0 +/-1.4 mg/dL, respectively, but this was not statistically significant. However, in the control group, the total cholesterol was increased by 9.4 +/-8.8 mg/dL, and the triglyceride was increased by 10.5 +/-7.2 mg/dL as compared to the baseline lipid level. Both of the results showed statistical significance. CONCLUSION: Alendronate might have a beneficial effect on lipid metabolism to decrease cholesterol and increase HDL. Taking into consideration about the postmenopausal increase in the cholesterol level, alendronate is recommended for the prevention of hyperlipidemia in postmenopausal women, in addition to preventing and treating osteoporosi

Citations

Citations to this article as recorded by  
  • The effect of alendronate on lipid profile of postmenopausal women with osteopenia and prediabetes
    Maryam Karimifard, Ashraf Aminorroaya, Massoud Amini, Ali Kachuie, Awat Feizi, Sima Aminorroaya Yamini, Moluk Hadi Alijanvand
    Journal of Research in Medical Sciences.2021; 26(1): 52.     CrossRef
Close layer
Case Report
A Case of Acromegaly with Diabetic Ketoacidosis and Hypertriglyceridemia-Induced Acute Pancreatitis .
Choon Young Lee, Moon Kyu Lee, Sun Young Lee, Sung No Hong, Hyung Hoon Kim, Bo Hyun Kang, Han Wook Kang, Byung Wan Lee, Yu Jeong Park, Yong Ki Min, Myung Shik Lee, Kwang Won Kim, Jong Hyun Kim
J Korean Endocr Soc. 2002;17(1):110-116.   Published online February 1, 2002
  • 1,447 View
  • 28 Download
AbstractAbstract PDF
Secondary diabetes mellitus caused by increased growth hormone secretion (GH) has well been known. There is a close association between glucose intolerance and GH secretion, and increased GH level itself probably worsens the blood glucose control and lipid profile by increasing glycogenolysis and / or gluconeogenesis and by suppressing lipase activity. We report a case of acromegaly with diabetic ketoacidosis as and hypertriglyceridemia-induced acute pancreatitis. A 38 year old male, previously diagnosed to have acromegaly and diabetes, presented with nausea, vomiting, diffuse abdominal pain and altered mentality. There was no history of drug or alcohol consumption, blood gas analysis showed severe acidosis and urinanalysis for ketone was positive. His serum blood glucose, amylase and lipase levels were 494 mg/dL, 331 U/L, and 1288 U/L, respectively (reference values: 70~110 mg/dL, 13~100 U/L and 13~190 U/L, respectively). The patient was diagnosed as having diabetic ketoacidosis and acute pancreatitis. With the serum concentration of triglyceride being 1488 mg/dL and the absence of any obvious precipitating factors, we considered hypertriglyceridemia to be the cause of acute pancreatitis. He was treated with continuous intravenous insulin infusion, lipid lowering agent, and fluid replacement. After conservative management, general condition gradually improved and his serum amylase, lipase and triglyceride levels were all normalized. GH level was not suppressed under 2 ng/mL during oral glucose loading test, and basal GH and IGF levels were 231 ng/mL and 29.5 ng/mL, respectively. Sella MRI showed a 3.7 cm sized pituitary mass. On the 55th day of admission, transsphenoidal surgery was performed. In immunohistochemical staining, the pathologic tumor specimen was proved to be GH positive pituitary adenoma. This is the first case reported in the English literature of an acromegaly presenting with diabetic ketoacidosis and acute pancreatitis
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP